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ABSTRACT 
Saccharomyces cerevisiae fermentation metabolites have been used for over a century 
as feed additives to improve the feed efficiency of food-producing animals.  During the 
routine microbiological monitoring of poultry houses, reports emerged indicating a 
significant decrease in Salmonella recovered from houses that recently contained broilers fed 
a yeast fermentation metabolite product (XPCTM) when compared to houses that recently 
harbored birds fed a conventional diet.  Preliminary studies evaluated the scope and breadth 
of this discovery, as well as the underlying mechanisms.  Based on these studies, we 
developed the hypothesis (central to this dissertation) that XPC has anti-Salmonella 
properties stemming from the immunomodulation of the mucosal immune system, possibly at 
the bridge between the adaptive and innate immune systems.  Addressing this hypothesis 
involved field studies evaluating the anti-Salmonella effects of XPC in cattle and poultry 
naturally infected with the pathogen.  Additional studies investigated the same parameters in 
experimentally infected animals.  These studies revealed that supplementing animals with 
XPC resulted in a significant reduction in the shedding and colonization of Salmonella, a 
reduction of integron- and plasmid- associated antibiotic resistance in input and naturally 
occurring Salmonella isolates, and the attenuation of pathogenicity of isolates obtained in 
both the field and laboratory settings.  Further studies explored the potential mechanism 
underlying the immunomodulatory effects of XPC after pilot studies revealed that leukocytes 
recovered from XPC-treated animals demonstrated an enhanced phagocytic clearance of 
Salmonella.  Additionally, gene expression studies revealed that this clearance phenomenon 
may be linked to enhanced local complement C3 expression observed in XPC-fed birds.  
Enhanced C3 production will lead to elevated production of complement C5, whose cognate 
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receptor is a druggable G-protein coupled receptor C5aR1 that plays a central role in 
enhancing the phagocytic capabilities of innate effector cells.  Thus, a series of in vivo 
experiments were conducted in order to ascertain the specific role that XPC plays in the 
improvement of innate immune activity via C5aR1.  Resulting evidence suggests that C5aR1 
may play a novel role in the immunostimulatory efficacy of XPC, which enhances the 
clearance of Salmonella.  Therefore, this thesis provides evidence supporting the anti-
Salmonella and immunostimulatory effects of XPC.  
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CHAPTER 1.   INTRODUCTION 
Since the formation of agrarian societies, farmers have faced numerous challenges 
associated with food animal production and management.  Ultimately, the goal of animal 
agriculture is to produce animals capable of yielding high-quality meat (Willems et al., 
2013), eggs (Herrero et al., 2013; Willems et al., 2013), and dairy products (Hayes et al., 
2013) in a cost-efficient manner.  A common metric associated with achieving this aim is 
termed feed efficiency, which is loosely defined as a reduction in the lifetime feed 
consumption of an animal while either maintaining or enhancing growth curves or yields 
(Herd and Arthur, 2009; Herrero et al., 2013).  Yeast fermentation metabolite byproducts 
have been used by producers for nearly a century to improve the production efficiencies of 
poultry, swine, meat goats, cattle, and aquaculture (Alizadeh et al., 2016; Chaucheyras-
Durand and Durand, 2010; Chou et al., 2017; E. Kairie, 2015; Feye et al., 2016; Hippen et 
al., 2010; Lensing et al., 2012; Mussatto et al., 2006; Poppy et al., 2012; Price et al., 2010; 
Titi et al., 2008; Xiao et al., 2016). 
A novel and unintended effect associated with the addition of yeast fermentation 
byproducts as a component of animal feed was discovered a few years ago through the 
routine microbiological surveying of poultry barns.  Farms began to use yeast fermentation 
metabolites, sold under the tradename XPCTM, as an in-feed additive to enhance feed 
efficiency in production poultry.  As a matter of standard practice, these barns were routinely 
monitored for environmental Salmonella during the cleaning phase in between production 
flocks (unpublished).  Evidence collected from generations of XPC-treated poultry suggested 
that within a few generations, there was a reduction of the prevalence of birds naturally 
infected Salmonella (unpublished).  Investigations were consequently initiated in order to 
2 
 
understand the potential applications, depth, and the underlying mechanisms associated with 
the ability of XPC to mitigate Salmonella.   
The central hypothesis of this dissertation is that XPC has properties that both reduce 
Salmonella virulence and enhance the innate immune clearance of the pathogen.  
Specifically, the enhanced immunological function converges at the G-protein coupled 
receptor C5aR1, which is the cognate receptor for the C5a complement protein.  This 
receptor serves not only as an important crossroad for the Host-Salmonella interaction, but 
also the nexus between the innate and adaptive immune system.  The resulting dissertation is 
an important contribution to our understanding of how yeast fermentation byproducts 
attenuate the pathogen as well as augment the innate immune system to enhance the 
clearance of pathogens.  In order to address this hypothesis, this thesis was executed and 
organized into the following six chapters: 
 
Chapter 2: A literature review documenting our current understanding of the threat of 
Salmonella, the application of XPC, and the immunobiology of the host-pathogen axis.  
Chapter 3: A ready-for-publication review outlining the history of XPC as well as the 
potential mechanisms associated with the efficacy of the product. 
Chapter 4: A published field study in beef cattle examining the reduction of Salmonella and 
Escherichia coli H7:O157 fecal shedding and lymph node infiltration of Salmonella in 
animals fed an XPC derivative. 
Chapter 5: A published study that evaluated the anti-Salmonella effects of XPC in broilers. 
Chapter 6: A series of experiments designed to explore the underlying mechanisms 
governing the enhanced phagocytic clearance of Salmonella enterica.  Specifically, this 
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investigation examined the role of the druggable G-protein coupled receptor C5aR1, which 
putatively enhances the clearance of Salmonella from broilers on an XPC containing diet.  
Chapter 7: The thesis concludes with a discussion of our findings and the context of our 
discoveries.  The future directions of this research are also outlined in this final section.  
 
Through these investigations, we deliver to the agricultural industry a renovation of 
an old, proven tool that enhances feed efficiency while simultaneously eliciting changes in 
Salmonella and the immune response.  In doing so, we continue the mission to further 
enhance food animal production and safety.  
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CHAPTER 2.   LITERATURE REVIEW 
2.1 The Threat of Salmonella 
Non-typhoidal Salmonella is the leading cause of foodborne illness in the U.S.  Direct 
exposure to raw meat, animal products, or cross-contamination events account for 95% of 
salmonellosis cases (Finstad et al., 2012; Mead et. al., 1999).  The most common Salmonella 
serovars implicated in foodborne illness are Enteritidis, Typhimurium, Heidelberg, Newport, 
and, in poultry, Kentucky (Finstad et al., 2012).  The instances of salmonellosis are 
consistent despite the implementation of new, data-driven mitigation strategies proposed as a 
result of advanced surveillance networks such as FoodNet and PulseNet (Besser, 2017; 
Finstad et al., 2012; Roto, et al., 2016).  Likely, the sustained instance of Salmonella 
underscores the pervasive nature of the pathogen (Besser, 2017).  
In the United States, poultry and cattle are the main reservoirs for Salmonella.  In 
poultry, Salmonella is a commensal organism (Chambers and Gong, 2011; Wigley, 2014).  
Salmonella contaminates poultry products by two routes: directly invading the reproductive 
tract and contaminating eggs, or sullying meat and skin during de-feathering and evisceration 
at the plant (Carrasco et al., 2012; Foley et al., 2013).  Poultry are recognized as the largest 
reservoir for Salmonella and abating this threat is a significant economic burden for poultry 
producers (Besser, 2017; Carrasco et al., 2012).  Beef cattle are also recognized as an 
emerging reservoir for Salmonella (Brichta-Harhay et al., 2008; Gragg et al., 2013; Terrance 
M. Arthur, 2008).  While some serovars (e.g., Dublin) can cause disease in cattle, other 
serovars of Salmonella are asymptomatically carried (Gragg et al., 2013, Selander et al., 
1992).  Peripheral lymph nodes have been found to contain Salmonella, even in 
asymptomatic animals (Gragg et al., 2013; Arthur et al., 2008).  These lymph nodes are 
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commonly incorporated into ground beef and are an emerging reservoir for Salmonella 
(Gragg et al., 2013; Arthur et al., 2008). 
Clinical salmonellosis is complicated by the emergence of multiple drug resistant 
strains and the transference of antibiotic resistance genes to other organisms.  Antibiotic-
resistant Salmonella account for 10-12% of Salmonella isolates identified through NARMS 
(National Antimicrobial Resistance Monitoring System) ( Schwarz et al., 2016).  This 
impacts the treatment of elderly, young, and immunocompromised patients who are at risk 
for bacteremia requiring antimicrobial therapy (Coburn et al., 2007; Kurtz et al., 2017; 
Tadesse et al., 2016).  Salmonella belongs to the family Enterobacteriaceae, which 
characteristically propagates antibiotic resistance genes through all known mechanisms of 
horizontal gene transfer (Huddleston et al., 2014).  Salmonella Typhimurium phagetype 
DT104 serves as a notable example of this problem (Leekitcharoenphon et al., 2016).  Many 
isolates of DT104 contain an integron conferring resistance to ampicillin, chloramphenicol, 
sulfonamides, streptomycin, and tetracycline (Tadesse et al., 2016).  The rise in antibiotic-
resistant salmonellosis is difficult to mitigate because mobile genetic elements like SGI1 
contain an extraordinarily stable toxin-anti-toxin system (Huguet et al., 2016; Michael and 
Schwarz, 2016).  The toxin-anti-toxin system prohibits the loss of the element once it is 
incorporated into the genome, thus enabling a sustained resistance to antibiotics (Huguet et 
al., 2016).  
Therefore, Salmonella poses additional challenges that are difficult to abate.  Pre-
harvest control measures are ideally pursued as current post-harvest strategies have not 
curbed the vertical transmission of Salmonella (Jones, 2011).  Accordingly, new strategies 
must diminish Salmonella from major reservoirs at the farm. 
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In the early 20th century, yeast fermentation products were discovered to improve 
production gains (J.J. Dibner, 2005).  One of these products, XPC, exhibits strong anti-
Salmonella effects.  These anti-Salmonella effects include reducing virulence, shedding, 
colonization, and antibiotic resistance (Feye et al., 2016).  Furthermore, XPC is able to 
surpass the benefits of antibiotics by improving the immune response and restoring antibiotic 
susceptibility in foodborne pathogens.  Therefore, XPC has the significant potential to be the 
next keystone in-feed additive in food animal production and management. 
2.2 XPC and its Production Benefits 
In the early 20th century, Diamond V discovered that dairy cattle fed XPC had 
increased milk production (Embria Health, 2013).  Using XPC has resulted in significant 
improvement in feed conversion ratios, a stabilization of the gut-microbiome axis, and anti-
pathogenic effects in chickens, turkeys, cattle, and pigs.  Furthermore, food animals fed XPC 
showed enhanced production efficiency and robustness in the face of biotic stressors (such as 
infectious diseases) and abiotic stressors (such as heat stress) (Feye et al., 2016; Gao et al., 
2008; Lensing et al., 2012; Osweiler et al., 2010; Price et al., 2010; Roto et al., 2017; S. 
Kumar, 2017; Xiao et al., 2016).  Importantly, recent discoveries indicate that XPC can be 
used to conciliate the threat of antibiotic resistance (Feye et al., 2016).    
Diamond V employs a vertically integrated process, starting with a standard strain of 
Saccharomyces cerevisiae to homogenously produce XPC.  S. cerevisiae are grown 
aerobically in complete media until the culture is in log phase (Nadler, 2011).  At that time, it 
is mixed with Distiller’s grains and transferred to the anaerobic fermentation vats.  Molasses 
was chosen as the carbohydrate source for anaerobic fermentation because it provides a 
complete source of monosaccharides required by Saccharomyces cerevisiae (Nadler, 2011).  
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The culture ferments anaerobically until metabolic activities cease.  The media is then 
collected, desiccated, and packaged (Nadler, 2011).  While the components of XPC are 
unknown, the metabolites produced by S. cerevisiae are likely influenced by the composition 
of the media used during anaerobic fermentation (Tiago et al., 2012; van der Aa Kuhle et al., 
2005).  All of the available products that Diamond V sells are derivations of the original XPC 
formulation (Nadler, 2011).     
The production benefits of XPC have been assessed in numerous studies.  Several 
studies indicate that, XPC improves meat, milk, and egg yield and quality in cattle and 
poultry (Alugongo et al., 2017; Brewer et al., 2014; Scott et al., 2015; Wagner et al., 2016; 
Xiao et al., 2016).  Figure 2.1 summarizes how the use of XPC improves food animal health 
and production.  The basis of these improvements stems from improved gut physiology, 
enhanced nutrient absorption, and beneficial changes to the microbiome.  As a result, food 
animals are healthier, grow more efficiently, and are more resistant to stress.  
The production gains are remarkable and beneficial throughout the life of cattle fed 
XPC (Scott et al., 2015).  The offspring of cattle on an XPC-containing diet are profoundly 
healthier with higher weaning weights (Wagner et al., 2016).  XPC-fed calves are also culled 
less due to weaning or shipping stress and respiratory infections (Scott et al., 2015; Wagner 
et al., 2016).  The continued use of XPC results in higher quality meat in beef cattle and milk 
in dairy cattle (Wagner et al., 2016).  These production benefits stem from improved rumen 
development with a concordant improvement in nutrient absorption (Alugongo et al., 2017; 
Brewer et al., 2014; Scott et al., 2015; Wagner et al., 2016; Xiao et al., 2016).  Moreover, 
cattle show greater microbial richness within the rumen, further improving its function (Xiao 
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et al., 2016).  Because cattle acquire 80% of their energy from cellulolytic bacteria in the 
rumen, this XPC-mediated enhancement is significant (Xiao et al., 2016).   
Additionally, the anti-pathogenic effects of XPC in cattle are now emerging in field 
studies.  Cattle on XPC have fewer liver lesions when compared to tylosin-fed controls, 
resulting in fewer condemnations at the packing plant (Scott et al., 2015).  Furthermore, there 
are anti-Salmonella effects whereby XPC yields an attenuated Salmonella and reduces 
prominent serovars like Dublin (Brewer et al., 2014; Feye et al., 2016)  
The XPC-mediated improvements in physiology and production in cattle have been 
paralleled in poultry.  As with cattle, the superior nutrient absorption of poultry on an XPC-
containing diet results from better gastrointestinal physiology (Kidd et al., 2013).  
Interestingly, the energy demanding metabolism of chickens requires resident 
microorganisms residing in the ceca to harvest short chain fatty acids.  This metabolism 
accounts for 25% of the nutritionally derived energy for the chicken (Roto et al., 2015).This 
effect is tied to increased market weights and superior breast quality of broilers (Kidd et al., 
2013).  In addition to improved feed efficiency, poultry show enhanced reproductive 
efficiency.  Hens fed an XPC-containing diet produce more fertile eggs with reduced 
contamination, resulting in healthier offspring entering the food supply (Kidd et al., 2013).  
Further, layers shed less Salmonella which effectively reduces the reservoir potential of eggs 
(unpublished data).  In meat birds, broilers and turkeys show a reduction in shedding and 
colonization of Salmonella.  Taken together, data indicates that there is not a commercial 
breed or species-specific effect of XPC (unpublished data). The ability of XPC to mitigate 
the threat of Salmonella is increasingly validated and vital as poultry are the leading source 
of Salmonella contamination.  
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While the production benefits of XPC are established, the mechanisms behind its 
efficacy are emerging.  Emerging research indicates that there are beneficial augmentations 
to host immunobiology that result in improved food animal health.  The first layer of the 
immune system is the barrier functions, and the use of XPC directly enhances gastrointestinal 
barrier integrity by improving the strength of the gap junctions between enterocytes 
(Possemiers et al., 2013).  This barrier function is further protected by an increased 
production of non-specific innate proteins, such as lysozymes and IgM (Evans et al., 2012; 
Jensen et al., 2007; Jensen et al., 2011; Possemiers et al., 2013).  Within the innate immune 
system, phagocytes show more active immunophenotypes (Chou et al., 2017; Jensen et al., 
2007; Possemiers et al., 2013).  There is also an increase in the production of chemokines 
and cytokines that assist in recruiting and activating effector cells to clear the invading 
pathogen (Evans et al., 2012; Jensen et al., 2007; Jensen et al., 2011; Possemiers et al., 2013).  
Interestingly, while XPC activates innate cells, it also beneficially tunes the inflammatory 
responses resulting in less non-specific inflammation (Jensen et al., 2007; Jensen et al., 
2011).  Finally, cell-mediated and humoral immunity are improved in animals on XPC (Chou 
et al., 2017).  Altogether, the tuned immunology of both branches of the immune system 
likely contribute to a healthier food production animal. 
The surprising consequence of using XPC is the reduction of antibiotic resistance.  
There are some clues as to this effect, though they are poorly understood.  Inflammation of 
the gut results in a bloom of Salmonella and other Enterobacteriaceae (Stecher et al., 2012).  
This bloom results in a favorable environment for horizontal gene transfer (Stecher et al., 
2012).  Taken with the established production and immune benefits, XPC produces a 
multifaceted improvement to the health and efficiency of food animals. 
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2.3 XPC at the Nexus of Salmonella Biology and Immunology 
Salmonella’s pathogenic assault of the gastrointestinal system requires a distinct 
series of events that not only alter the microenvironment of the lumen, but effectively shut 
down the immune system.  The complement pathway is a significant component of the 
immune response to Salmonella.  Interestingly, the complement pathway is optimized in 
animals on an XPC-containing diet.  As complement proteins are upregulated in animals on 
an XPC-containing diet, perhaps the repeated activation of this pathway may contribute to 
the anti-Salmonella effects.   
Salmonella gains entry into the gastrointestinal tract through the host’s ingestion of 
contaminated food or water.  From there, the sole goal of the pathogen is to become 
intracellular, either through phagocytosis or invasion, which occurs within 15 minutes of oral 
challenge (Kurtz et al., 2017; van Hemert et al., 2006; Wigley, 2014).  Salmonella hones to 
its preferential invasion sites using the Aer and Tsr chemotactic receptors (Coburn et al., 
2007).  These sites include enterocytes, secretory goblet cells, and microfold cells (M-cells) 
(Coburn et al., 2007; Keestra-Gounder et al., 2015).The initial inflammatory events are 
driven by one of three events: engagement of the immune system, (Salmonella Pathogenicity 
Island) SPI-1-mediated inflammation or by the Salmonella virulence factors (Keestra-
Gounder et al., 2015; Kurtz et al., 2017; van Hemert et al., 2006; Zhang et al., 2017).  As a 
result of the inflammatory reactions of infiltrating neutrophils, thiosulfate is oxidized to 
tetrathionate by Salmonella or by the presence of reactive oxygen species in the lumen 
(Rivera-Chavez and Baumler, 2015).  Tetrathionate is the favored terminal electron acceptor 
of Salmonella and enables it to out-compete resident microorganisms and upregulate its 
invasion machinery (Rivera-Chavez and Baumler, 2015).  Typically, in a stable, non-
inflammatory gut, Salmonella is inert and weakly competitive (Rivera-Chavez and Baumler, 
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2015).  To reach its full pathogenic potential, Salmonella requires inflammation (Rivera-
Chavez and Baumler, 2015; van Hemert et al., 2006).   
However, inflammation is a double-edged sword for Salmonella.  On one hand, the 
production of inflammation as a result of the T3SS (Type III Secretion System) SPI-1 
engagement of the host intracellular machinery produces inflammation.  This activity is 
imperative to the success of the pathogen as inflammation enhances the pro-Salmonella 
metabolite changes in the lumen, resulting in a bloom in Salmonella (Ciraci et al., 2010; 
Coburn et al., 2007; Endt et al., 2010; Rivera-Chavez and Baumler, 2015; van Hemert et al., 
2006).  On the other hand, without the engagement of the immune system, the host is unable 
to resolve the infection (Coburn et al., 2007; Hurley et al., 2014).  Therefore, Salmonella acts 
to continuously optimize the inflammatory environment through its T3SS and virulence 
factors.  
The invasion of Salmonella into the gastrointestinal lumen is mediated by the T3SS, 
which acts to both activate and circumnavigate the host immune response in both non-
phagocytic and phagocytic cells (Golubeva et al., 2016; Golubeva et al., 2012; Hapfelmeier 
et al., 2005; Keestra-Gounder et al., 2015; Rivera-Chavez and Baumler, 2015; Serhan et al., 
2008).  Invasion occurs via either the trigger or zipper mechanism (Velge et al., 2012).  Both 
mechanisms are dependent on the upregulation of hilA, the master regulator of the T3SS 
(Bajaj et al., 1995).  As shown in Figure 2.2, the trigger mechanism utilizes an injectisome, 
or molecular needle, to form a 3.5 nm pore in the host cell (Velge et al., 2012).  The 
injectisome is then the conduit to deliver SPI-1 effector molecules into the cytosol.  These 
molecules target the actin/cytoskeleton machinery that lead to a rippling of the phospholipid 
bilayer (Velge et al., 2012).  Consequentially, Salmonella is passively engulfed by the host 
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cell (Velge et al., 2012).  Additionally, the SPI-1 proteins also target NLRP3 and NLRP4 
inflammasomes and the activation of NF𝜅B.  These actions ultimately promote inflammation 
(Raymond et al., 2013; Velge et al., 2012).  The second mechanism used by Salmonella to 
invade host cells is termed the zipper mechanism (Velge et al., 2012).  This mechanism is 
initiated by the RCK protein interacting with an unknown host receptor resulting in receptor-
mediated endocytosis (Velge et al., 2012). 
Regardless of the invasion mechanism undertaken, Salmonella are then subject to one 
of two fates: cytosolic replication and survival or encasement within the Salmonella 
containing vacuole (SCV) (Hapfelmeier et al., 2005; Herrero-Fresno and Olsen, 2017; 
Keestra-Gounder et al., 2015; Knodler, 2015).  The inflammation results in apoptotic cell 
death as an outcome from the detachment of cells from the extracellular matrix.  The dead 
cells release the bacteria back into the gut and contribute the clinical signs of enterocolitis 
(Knodler, 2015).  Together, this massive release of bacteria and the inflammation strengthens 
the effects of the invasion machinery and feeds forward the pathogenesis of Salmonella. 
Because the initial inflammation is beneficial for Salmonella, the pathogen hijacks 
this process independent of the T3SS.  The Salmonella surface protein PgtE is an outer 
membrane aspartate protease that cleaves C3 to produce C3a and C3b (Ramu et al., 2007).  
This can initiate the alternative complement pathway producing C5a which instigates 
inflammation (Ramu et al., 2007; Schraufstatter et al., 2002) Salmonella is then able to 
circumnavigate its own death by the proteins Rck, TraT, and PagC that prohibit the formation 
of the membrane attack complex and prevents lysis (Ramu et al., 2007).  Moreover, the Vi 
capsular polysaccharide found in several serovars prevents the deposition of complement 
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proteins onto the surface (Keestra-Gounder et al., 2015).  Thus, Salmonella regularly 
manipulates or evades the complement pathway. 
Once the Salmonella are intracellular, the pathogen subverts immune surveillance 
which reduces inflammatory pathway activation and xenophagy.  In order to evade the 
immune system, the intracellular survival of Salmonella requires a series of orchestrated and 
well-timed T3SS-mediated events (Ciraci et al., 2010; Oshota et al., 2017; Razzuoli et al., 
2017; van Hemert et al., 2006).  There are two main pathogenicity islands required: SPI-1, 
whose second-stage induction suppresses the intracellular detection of Salmonella; and, SPI-
2-mediated quiescence of the SCV (Keestra-Gounder et al., 2015).  Immune suppression 
governed by the SPI-1 effector proteins results in evasion of the intracellular NOD receptors, 
cessation of xenophagy, and the maturation of the SCV via Salmonella proteins like SopB 
and SteA (Keestra-Gounder et al., 2015; Knodler, 2015; Raymond et al., 2013).  If 
successful, this initial phase of invasion enables the SCV to evade intracellular host pattern 
recognition receptors (Keestra-Gounder et al., 2015).  The SCV will then locate itself 
between the Golgi apparatus and the endoplasmic reticulum in a SPI-2 mediated quiescent 
state until reactivation via SPI-1 (Herrero-Fresno and Olsen, 2017).  
The immune system must effectively engage in order to override the Salmonella 
resistome.  The effective activation of the immune system is through one of two routes: 
through the recognition of Salmonella LPS by TLR4 present on resident macrophages and 
neutrophils; or, via the complement pathway (Kurtz et al., 2017).  Ligation of TLR4 on 
resident neutrophils or macrophages (or heterophils in Aves) causes a massive production of 
cytokines (Coburn et al., 2007; Janeway and Medzhitov, 2002).  This leads to both the 
activation of innate and adaptive cells, as well as their infiltration into the lamina propria  
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(Kurtz et al., 2017).  Additionally, the complement pathway recognizes Salmonella which 
results in opsono-phagocytosis, lysis, and the production of C5a (Ramu et al., 2007).  A vital 
element in overcoming the ability of Salmonella to hijack the host is the synergism 
associated with the actions of the Toll-like receptors and the complement pathway.  These 
synergistic pathways likely converge on MAPK and lead to a successful immune response to 
Salmonella (Sarma, 2012).  In host-restricted serovars of Salmonella, gene loss events lead to 
a reduction of inflammation that facilitates the ability of Salmonella to successfully evade the 
immune system (Foley et al., 2013; Golubeva et al., 2012; Klerks et al., 2007; Knodler, 2015; 
Oshota et al., 2017; Razzuoli et al., 2017; Selander et al., 1992).  This is likely due to a 
highly tuned activation of its T3SS (Diepold and Armitage, 2015; Raymond et al., 2013; 
Velge et al., 2012). 
Eventually in immunocompetent patients the immune response will resolve 
salmonellosis.  The C5aR1 receptor is an important buttress to the clearance of Salmonella as 
its actions are imperative for resolution of the infection.  The C5aR1 receptor is ligated by 
C5a as a consequence of activating the complement pathway (Brodbeck et al., 2008; Karsten 
et al., 2015; Klos et al., 2009; Lee et al., 2008).  The complement pathway is an ancient, 
evolutionarily conserved set of over 50 proteins that act in concert to kill pathogens and clear 
damaged cells from the host (Klos et al., 2009; Kolev et al., 2014).  The specific pathways of 
activation are summarized in Figure 2.3 (Kolev et al., 2014).  When activated, complement 
has three effects: to facilitate opsono-phagocytosis, to promote inflammation, and to produce 
the membrane attack complex leading to cellular lysis (Klos et al., 2009; Kolev et al., 2014; 
Lee et al., 2008).  There are three pathways that feed into complement and include the 
classical, lectin, and alternative pathways.  Kallikren and thrombin can also activate the 
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alternative pathway by cleaving C3 leading to the formation of C3 convertase (Klos et al., 
2009; Kolev et al., 2014; Lee et al., 2008).   
 The C5a anaphylatoxin is an essential component in producing an inflammatory 
response to Salmonella and as well as its clearance.  Traditionally, complement proteins are 
produced in the liver (Klos et al., 2009; Kolev et al., 2014; Lee et al., 2008).  However, 
recently it has been demonstrated that antigen-presenting cells can produce complement 
proteins to stimulate T-cells and enhance their activity (Boothby et al., 2015; Klos et al., 
2009; Kolev and Kemper, 2017; Kolev et al., 2014; Lee et al., 2008).  As a result, there is 
significant cross-talk between the adaptive and innate immune system through this receptor 
(Klos et al., 2009; Kolev et al., 2014; Lee et al., 2008).  Antigen-presenting cells secrete C3 
and C5, and T-cells activate these proteins via cathepsin L.  Both C3a and C5a ligate their 
cognate receptors and aide in the production of a beneficial inflammatory environment (Klos 
et al., 2009; Kolev et al., 2014; Lee et al., 2008).  The autocrine-driven responses to C3a and 
C5a are essential for a productive Th1 response to intracellular pathogens (Klos et al., 2009; 
Kolev et al., 2014; Lee et al., 2008).  Therefore, complement has significant effects 
throughout the entirety of the immune response—both locally and systemically.   
The enhancement of complement activation is implicated in the success of XPC in 
improving the immune response to a Marek’s vaccine challenge (Chou et al., 2017).  This up-
regulation likely beneficially modulates the immune system and enables animals fed an XPC-
containing diet to respond with a more tuned, efficient, and effective response to vaccination 
(Chou et al., 2017).  Other research indicates that feeding animals XPC corresponds to a 
better phagocytic clearance of pathogens (Chapter 3).  There is also a reduction in the 
dissemination of Salmonella to the peripheral lymph nodes (Feye et al., 2016).   
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The cellular response of the C5aR1 receptor is well-understood, though its molecular 
pharmacology remains complicated.  C5aR1 is encoded in the mammalian genome as two 
exons, though that conservation does not necessarily exist in non-mammalian species 
(Higginbottom et al., 2005; Karsten et al., 2015; Klos et al., 2013; Lagerstrom et al., 2006; 
Rabiet et al., 2007).  The C5aR1 receptor is expressed in all of the leukocyte lineages as well 
as in the spleen and liver (Klos et al., 2013; Lee et al., 2008).  C5aR1 is a pertussis toxin-
sensitive G-protein coupled receptor that belongs to the rhodopsin family of receptors (Klos 
et al., 2013s).  Activation of this receptor immediately results in the reduction of cAMP, an 
influx of calcium, and the phosphorylation of AKT/PI-3K as summarized in Figure 2.4.  As a 
consequence of receptor activation, there is enhanced cytokine expression, improved antigen 
presenting receptor and co-receptor expression, and superior phagocytosis (Bajic et al., 2013; 
Brodbeck et al., 2008; Higginbottom et al., 2005; Karsten et al., 2015; Klos et al., 2013; Lee 
et al., 2008; Li et al., 2012; Ricklin et al., 2012; Schraufstatter et al., 2002).  In most animals, 
but not necessarily in poultry, the C5aR1 receptor is a member of the n-formyl peptide family 
of chemotactic receptors (Klos et al., 2013; Lagerstrom et al., 2006).  Thus, the engagement 
of this receptor is almost universally tied to the infiltration of neutrophils during Salmonella 
invasion (Coburn et al., 2007; Kurtz et al., 2017).  Through numerous studies, it appears that 
the cellular response as a result of receptor engagement is conserved across taxa (Bajic et al., 
2013; Brodbeck et al., 2008; Higginbottom et al., 2005; Karsten et al., 2015; Klos et al., 
2013; Lee et al., 2008; Li et al., 2012; Ricklin et al., 2012; Schraufstatter et al., 2002).  
Overall, tuning the microbiome and improving the innate effector response may lead 
to the profound anti-Salmonella effects demonstrated by XPC.  Therefore, the probable 
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mechanisms of XPC intersect at the nexus of Salmonella pathogenesis, the microbiome, and 
immunobiology.  
 
2.4 Conclusions 
Food animal production will always need to meet the demand of the people with a 
constant eye towards economics, animal welfare and food safety.  The collateral damage 
associated with the off-label use of antibiotics is austere and unpredictable.  Through 
replacing antibiotics as in-feed additives with postbiotics like XPC, the goals set forth by 
food animal scientists to feed the world are furthered.  XPC improves food safety, feed 
conversion, and the health of the host.  While there is mechanistic variation between species, 
the relative consistency is promising.  
Notably, understanding the underlying mechanisms associated with the efficacy of 
the product will result in additional discoveries to further improve the product or expand on 
its utilization.  This understanding could lead to enhanced drug targeting strategies and 
immune based technologies to improve animal health.  Thus, the impending food and the 
antibiotic resistance crisis may have a solution.  
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2.5 Figures 
 
Figure 2.1 Benefits of XPC in Food Animals.  XPC is traditionally used in food animal 
production to improve feed efficiency.  XPC has three major effects on the host: improving 
the host immune system, modulating the microbiota, and augmenting the gastrointestinal 
physiology to improve nutrient absorption.  These changes lead to the improve the 
immunobiological functioning of the host as well as the microenvironment of the 
gastrointestinal lumen.  As a result, the changes lead to the reduction in Salmonella and other 
pathogens from food animals. 
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Figure 2.2 Salmonella Invasion Mechanisms. This series of diagrams and photographs 
show how Salmonella invade the host.  This figure is taken from Vegle et al., 2012.  (A) This 
is the author’s rendition of the trigger mechanism of invasion.  The injectasome forms a pore 
on the surface of the host cell membrane and injects the SIPA, SIPB, SIPC, SIPE2, and SIPE 
SPI-1 effector proteins into the cytosol.  These proteins engage the host cytoskeleton 
remodeling machinery and ultimately form a ripple in the host membrane.  The Salmonella 
then slips into the host cell.  (B) This image is a scanning electron micrograph of this event.  
(C) This diagram describes the zipper mechanism of invasion.  Salmonella RCK docks with 
some unknown host receptor, which initiates receptor mediated endocytosis.  (D) This image 
is a scanning electron micrograph of this event. 
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Figure 2.3 Complement Pathway. The Complement Pathways is described above and 
the figure is directly taken from Kloev et al., 2014.  (A)  This is a diagram of system 
complement activation includes the regulatory checkpoints and the consequences for 
activating this pathway.  (B) This is a diagram of the lesser known local complement 
pathway.  Antigen presenting cells and T-cells produce local complement proteins whose 
autocrine and paracrine signaling activates receptors that promote a beneficial inflammatory 
environment.  The tuned inflammation ensures the proper activation of immune effector 
cells. 
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Figure 2.4 C5aR1 Cell Signaling Cascade and Response. The activities of this receptor 
vary depending on the cell-type expressing this receptor.  However, the end result seems to 
be conserved.  That is, the activation of C5aR1 increases cell survival and proliferation, 
enhances the response to inflammatory stimuli, and regulates autophagy. (Lagerstrom et al., 
2006; Wettschureck and Offermanns, 2005) 
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3.1 Abstract 
Due to regulations set forth by the Veterinary Feed Directive, as of January 1, 2017, 
feed grade antibiotics will be restricted in food animal production.  Some defining 
characteristics associated with feed grade antibiotics are the inhibition of important 
pathogens, enhanced growth, and improved performance.  Recent research reveals that a 
fermentation product, XPCTM (Diamond V, Cedar Rapids, IA), serves as a viable alternative 
across multiple food animal species including cattle and poultry.  Providing this supplement 
in the feed of animals leads to reduced prevalence, load, virulence, and antibiotic resistance 
of foodborne pathogens such as Salmonella and Escherichia coli O157:H7.  These findings 
are compelling, especially when coupled with the enhanced growth and performance 
observed with these products.  Mechanistically, XPC appears to modulate these effects 
through the immune system and gut microbiome.  Use of fermentates like XPC can lead to an 
overall reduction of antimicrobial resistance, enhanced herd health, and a reduction in the 
vertical transmission of important foodborne pathogens.  Through continued research and 
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exploration, the development of XPC as an alternative to feed-grade antibiotics will augment 
the fight against foodborne pathogens. 
3.2 Introduction 
The persistence of important foodborne pathogens continues to prove a formidable 
challenge to overcome with futile attempts to halt vertical transmission to the food supply 
outnumbering the successes.  Two of the more important foodborne pathogens, Salmonella 
enterica and shiga toxin producing Escherichia coli O157:H7 (STEC), are serious concerns 
in food animal production management.  Salmonella enterica is a ubiquitous, zoonotic 
pathogen that is an enduring challenge in food animal production and management (Jones, 
2011).  Control of Salmonella in production animals occurs in pre-harvest and post-harvest 
settings (Jones, 2011), without universal success.  That is, despite a concerted effort to 
prevent the transmission of Salmonella throughout the food production chain, control 
mechanisms routinely fail.   
At animal processing facilities, surveillance is a key for evaluating control 
mechanisms that halt the perpetuation of enteric pathogens.  Harvest facilities heavily rely on 
routine visual, molecular, and microbiological surveillance of equipment for enteric 
pathogens with disinfection serving as a mainstay of the abatement process.  The 
implementation and execution of all control and surveillance mechanisms face their own 
unique set of economic and implementation challenges, and unfortunately are not fail-proof 
(Jones, 2011).  Efficacious pre-harvest abrogation of Salmonella and other enteric pathogens 
will obviously halt transmission to the processing facilities and as a result markedly reduce 
introduction of pathogens into the food chain (Jones 2011; Tadesse 2016). 
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On-farm approaches that prevent the transmission of Salmonella and other enteric 
pathogens have two separate branches: the traditional and the alternative.  Traditional 
abatement procedures include vaccination, feed-grade antibiotics (FGAs), chemical 
treatments of feed and water, and disinfectants used at the facilities housing the animals.  
Perhaps the most ignoble consequence of FGAs is the correlation between FGAs and the 
emergence of multiple drug resistant bacteria in veterinary and human clinical settings (Foley 
et al., 2013).  While some controversy still exists as to the outcome of banning FGAs in food 
animal production, the potential contribution of this approach to the over-utilization of 
antibiotics should not be ignored (Casewell et al., 2003; Wegener, 2003).   
With the advent of the Veterinary Feed Directive (FDA, 2017), alternatives to FGAs 
must be identified.  Alternative methods to prevent the transmission of Salmonella include 
using essential oils, modulation of the microbiota directly through seeding, facilitating 
healthy microbiota through biotics (prebiotics, postbiotics, and probiotics) and bacteriophage 
seeding (Brewer et al., 2014; Feye et al., 2016; Feye et al., 2016; Kenneth A. Kudsk, 2002; 
Torres-Barcelo and Hochberg, 2016).  Herein we discuss fermented products as a control 
measure for enteric pathogens.   
There is evidence that the utilization of fermented products, in particular the 
Saccharomyces cerevisiae fermentation product designated as XPCTM, impacts enteric 
pathogens across multiple livestock species through a possible conserved mechanism.  A 
fermented product is a collection of metabolic byproducts produced from commensal 
microorganisms and/or symbionts, such as Saccharomyces cerevisiae, that exert a non-
specific yet beneficial biological activity in the host (Patel et al., 2014).  Traditionally, XPC 
is used for its beneficial production effects.  However, studies into its anti-pathogenic effects 
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began after anecdotal observations indicated that there was a decrease in Salmonella 
prevalence in chicken laying barns as part of the National Poultry Improvement Plan 
environmental monitoring.  Questions began to emerge as to the potential use and efficacy of 
XPC as a pathogen mitigation tool, as well as the mechanisms underlying its effects.  Recent 
and ongoing studies suggest that XPC is a potent intervention with uses in poultry, egg, 
dairy, and feedlot production.  Herein we discuss the evidence and mechanisms regarding 
XPC as a cost-effective alternative to antibiotics.  This review specifically focuses on STEC 
and Salmonella enterica, two important causative agents of world-wide foodborne illnesses.   
 
3.3 Current Evidence Revealing the anti-Salmonella Effects of XPC and Derivatives 
3.3.1 Anti-Salmonella Effects of XPC in Dairy Calves 
Fermentation products (FPs) have been added to livestock feed as growth promoters 
whereby these supplements favor sound gut development (Lesmeister et al., 2004; Price et 
al., 2010).  In cattle, FPs apparently improve average daily gain and increase feed efficiency.  
Immunologically, FPs are mechanistically tied to an increase in overall immune function 
through the modulation of the host immune surveillance and inflammatory response (Jensen 
et al., 2008; Jensen et al., 2007; Lesmeister et al., 2004).  Furthermore, it is proposed that 
XPC fosters an increase in intestinal butyrate (Lesmeister et al., 2004)- an important fatty 
acid in ruminant metabolism.  An additional benefit of butyrate is its ability to down-regulate 
the expression of genes in Salmonella pathogenicity island 1 (SPI1), a collection of about 40 
genes that facilitate gut epithelial cell invasion and systemic virulence (Foley et al., 2013).  
Given the aforementioned potential anti-Salmonella effects of XPC in ruminants and 
the anecdotal reports of XPC-mediated reduction in Salmonella in poultry, the anti-
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Salmonella effects of XPC were examined in dairy calves.  Salmonella was of interest due to 
its persistence on the farm, the disease-associated retardation of the growth and development 
of dairy cattle, and the emergence of hypervirulent multi-drug resistant strains (Carlson et al., 
2007; Rasmussen et al., 2005).  One study addressed the hypothesis that XPC plus 
SmartCareTM, an XPC derivative that is included in milk replacer, reduces the impact of 
Salmonella in dairy calves on milk (Brewer et al., 2014).  Calves were fed SmartCare plus 
XPC for two weeks prior to experimental infection with multi-resistant Salmonella 
Typhimurium DT104.  When compared to calves fed the Control diet, XPC plus SmartCare 
lead to beneficial anti-Salmonella effect resulting in a decrease in rectal temperature, diarrhea 
scores, and fecal shedding, as well as an with an overall improvement in rumen development 
and body weight gain (Brewer et al., 2014).  Interestingly, and important for long-term 
control of Salmonella at the farm, there was a decrease in the ileal colonization of Salmonella 
in the calves fed XPC plus SmartCare.  Therefore, the study suggests that the consequences 
of feeding calves XPC plus SmartCare is an overall improvement of gastrointestinal health 
and development as well as a profound reduction in Salmonella load and virulence (Brewer 
et al., 2014).  
3.3.2 Anti-Salmonella Effects of XPC in Beef Cattle 
The positive results from the dairy calf studies prompted analogous studies in beef 
cattle using an XPC derivative designated as NaturSafeTM.  This study examined the effects 
of NaturSafe on fecal shedding, lymph node infiltration, virulence, and antibiotic resistance 
of Salmonella as well as the prevalence and load of E. coli O157:H7 (Feye et al., 2016).  
Cattle were fed either a standard industry diet containing monensin, tylosin, and bovamine 
(Control group) or a diet lacking these three constituents but containing NaturSafe.  Results 
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indicated that NaturSafe mediated an approximate 50% decrease in Salmonella load across 
pens, a four-fold decrease in Salmonella shedding, and a seven-fold decrease in Salmonella 
infiltration to the lymph nodes when compared to the Control diet (Feye et al., 2016).  
Regarding virulence, there was about a 65% reduction in Salmonella virulence as measured 
by decrease in both hilA expression and tissue culture invasiveness (Feye et al., 2016).  This 
is extrapolated to an approximate five-fold increase in the dose of Salmonella needed to 
infect and cause salmonellosis in a non-ruminant (Carlson et al., 2000).  Furthermore, there 
was a significant reduction of antibiotic resistant phenotypes of Salmonella and a reduction 
in more aggressive and epidemiologically relevant Salmonella serotypes such as 
Typhimurium, Dublin, and Newport.  Regarding E. coli O157:H7, there was over a 50% 
reduction in fecal load and a 20% reduction in prevalence.  These data suggest that there is an 
overall decrease in virulence, antibiotic resistance, load, and prevalence of Salmonella in 
cattle fed NaturSafe verses those fed a standard industry diet (Feye et al., 2016) which 
contains an ingredient (tylosin) that will be restricted  2017.  Although tylosin is included in 
the diet for controlling liver abscesses and is not intended for control of Salmonella, its 
absence may increase the incidence of liver abscesses.  However, there is evidence that the 
NaturSafe-fed cattle had indistinguishable incidences of liver abscesses when compared to 
cattle fed the Control diet containing tylosin (unpublished).   
3.3.3 Anti-Salmonella Effects of XPC in Poultry 
Salmonella is not typically a pathogen in poultry since avian salmonellosis is 
restricted to a few serotypes that are mostly absent from the U.S.  The central concern in 
poultry involves the vertical transmission of the zoonotic pathogen to the human population.  
A study was conducted to look at the anti-Salmonella properties of XPC in regards to the 
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load, prevalence, virulence, and antibiotic resistance of Salmonella in a controlled 
experiment with broilers.  One day-old chicks were repeatedly infected with multiple 
antibiotic resistant Salmonella Typhimurium DT014 from days 2 to 20 (Feye et al., 2016).  
Uninfected chicks were removed on day 21 and remaining chicks were fed either a diet 
containing XPC or a Control diet lacking XPC.  Fecal and cecal samples were taken from the 
birds and selective culture for Salmonella revealed a reduction of load and prevalence of 
Salmonella as well as a reduction in virulence and antibiotic resistance (Feye et al., 2016).  
Evidence for a reduction in virulence came from a reduction in the expression of hilA, a gene 
whose expression is central to Salmonella invasion through the Type III Secretion System 
(Foley et al., 2013), concordant with a decrease in Salmonella invasiveness as measured by a 
tissue culture-based invasion assay (Gianella et al., 1973).  The reduction in antibiotic 
resistance correlated with the loss of the SGI1 integron from the input strain.  Studies are 
ongoing regarding the potential mechanism associated with the anti-Salmonella activities of 
XPC in poultry.  
 
3.4 Additional Evidence Supporting the anti-Salmonella Effects of XPC and 
Derivatives in Calves 
3.4.1 Immune Clearance of Salmonella in Dairy Calves 
The study with SmartCare and XPC revealed diminished Salmonella shedding and 
carriage in calves fed the products, when compared to calves fed the Control diet.  Both 
groups were infected with the same dose of Salmonella yet the Treated group appeared to be 
clearing the pathogen (Brewer et al., 2014).  Two possible explanations are that the XPC-fed 
calves were either capable of killing the Salmonella or that these calves were more efficient 
at translocating the Salmonella to lymph nodes. 
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To address the first possibility, we examined peripheral blood cells for the ability of 
the leukocytes to kill the Salmonella.  Specifically, whole blood was taken and incubated 
with Salmonella for 1 hour.  After 1 hour, a portion of leukocytes were removed and exposed 
to gentamicin in order to kill the non-engulfed/non-invasive Salmonella.  Leukocytes were 
then lysed with Triton and lysates were plated on XLD that incubated overnight at 37oC for 
colony enumeration the next day.  This process was repeated at multiple time points in order 
to determine the ability of the leukocytes to temporally kill Salmonella.  As shown in Figure 
3.1, the number of Salmonella was equivalent in both groups of calves (n=5 calves/group) at 
the first time point but the numbers of Salmonella dropped dramatically at each successive 
time point for leukocytes obtained from XPC-fed calves.  Importantly, this mechanism seems 
to be conserved across two divergent Salmonella enterica serovars—Typhimurium and 
Dublin.   
To address the second possibility, peripheral lymph nodes (superficial cervical) were 
excised at euthanasia and subjected to selective culture for Salmonella.  An increase in 
Salmonella recovered from the lymph nodes would indicate the pathogen was able to evade 
host immune responses, and arrive at the lymph nodes in a viable state.  Such viability is not 
possible if there is sufficient phagocytic killing of the Salmonella, and subsequent processing 
for antigen presentation (Levy et al., 2015; Vieira et al., 2016).  As shown in Figure 3.2, 
Salmonella was significantly less abundant in lymph nodes from XPC-fed calves.  Thus it 
appears that leukocytes from XPC-fed calves are more efficient at killing Salmonella while 
lymph nodes from these calves are less likely to harbor Salmonella. 
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3.4.2 Diminished Virulence and Antibiotic Resistance of Salmonella in Dairy 
Calves 
Since the input strain used in the poultry studies (Feye et al., 2016) was also used in 
the calf studies (Brewer et al., 2014), similar virulence and antibiotic resistance assays were 
performed using Salmonella recovered from the calves.  As shown in Figure 3.2, tissue 
culture invasiveness, hilA expression, antibiotic resistance, and prevalence of the antibiotic 
resistance element (SGI1) were all diminished in Salmonella recovered from XPC-fed calves. 
3.4.3 Restoration of Salmonella Invasion after the Pathogen Exits an XPC-fed 
Host 
To investigate the possibility that the hypo-invasive Salmonella recovered from 
animals fed XPC have the potential to quickly return to the fully invasive state after exiting 
an XPC-fed animal, a series of temporal invasion assays were performed on isolates 
recovered from XPC-fed poultry and cattle.  As shown in Figure 3.3, invasiveness returns 
after three successive incursions into tissue culture cells and the invasion does not go above 
that observed for Salmonella recovered from Control-fed animals.  Thus it appears that, after 
exiting an XPC-fed animal, the Salmonella need to invade three hosts before returning to the 
fully virulent state. These data include Salmonella obtained from the experimentally infected 
dairy calves (Brewer et al., 2014a), naturally infected beef cattle (Feye et al., 2016), and from 
poultry that were experimentally infected (Feye et al., 2016) and naturally infected.  Thus the 
data represent a variety of Salmonella serotypes in a variety of hosts. 
 
3.5 Conclusions 
Through the implementation of XPC as a feed additive, there is a clear advantage for 
the reduction of important foodborne illnesses in food animal production.  Evidence 
31 
 
continues to show that XPC leads to a reduction in Salmonella antibiotic resistance, load, 
virulence, prevalence, and shedding across multiple species.  The mechanism of the reduced 
invasiveness, and deduced virulence, converges in a reduction in SPI-1 and hilA in 
Salmonella recovered from both cattle and chickens.  Further, the Salmonella recovered from 
treated animals have a sustained increase in dose required to cause disease.  Not only is a 
reduction in prevalence important, but XPC directly decreases antimicrobial resistance which 
is the focus of the VFD.  The anti-resistance benefit is two-fold.  The first benefit is a 
reduction in SGI1 in MDR Salmonella DT104, which reduces the presence of genes 
associated with drug resistance (Feye et al., 2016).  The second is likely beneficial in years to 
come following the cessation of unnecessary antibiotics in feed animals, thus reducing the 
evolutionary pressure to maintain resistant genotypes within a population.  
The conserved mechanism for XPC efficacy relating to its anti-Salmonella effects is 
largely unknown.  Research has been initiated to elucidate this interesting mechanism, 
though the literature is highly suggestive of two mechanisms: augmenting gut 
immunophysiology and enhancing microbial competition.  Sustained inflammation resulting 
from any number of sources ultimately leads to a reduction in gut-barrier integrity, increases 
circulating endogenous endotoxin, and is linked to decreased residual feed intake and 
susceptibility to disease in food animals (Gaggìa et al., 2010; Mani et al., 2012; Turner, 
2009).  The utilization of fermented products specifically addresses that issue, leading to 
enhanced gut physiology resulting in reduced pathogenesis of important foodborne pathogens 
across multiple species (Brewer et al., 2014; Feye et al., 2016; Feye et al., 2016; Vieira et al., 
2016).  
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Further mechanistic potentials for XPC exist in the enhancement of commensal 
microbial populations directly.  This enhancement improves competition, gastrointestinal 
physiology, and nutrient utilization.  The use of prebiotics enhances gut villi morphology 
through a manipulation of the gut microbiome in poultry (Pan and Yu, 2014) and cattle 
(Brewer et al., 2014).  Further studies into beneficial exudates from microbial populations 
categorized as prebiotics include: short chain fatty acids, aromatic amino acid derivatives, 
vitamins, enzymes that catalyze the de-hydralization and de-conjugation of bile acids to 
enhance vitamin absorption, and choline (Krishnan et al., 2015).  The product XPC 
potentially goes beyond that, though the specific components and mechanisms are unknown.  
Nonetheless, the underlying mechanism governing the success of XPC may also be pertinent 
to the reduction of other pathogens that extend beyond zoonoses identified in this review.  
Therefore, XPC has the potential to be a significant and economically viable solution for 
curtailing foodborne pathogens and further studies will continue to enhance our 
understanding of postbiotics on physiology. 
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3.6 Figures 
 
Figure 3.1 Assessment of Salmonella obtained from lymph nodes of calves fed XPC 
plus SmartCare compared to the control. Newborn dairy calves were fed daily doses of 
XPC plus SmartCare for five weeks (Brewer et al., 2014).  At the end of the study, calves 
were euthanized and Salmonella were cultured from the superficial cervical lymph nodes.  
Salmonella were enumerated and subjected to the virulence and antibiotic resistance assays 
described in other studies (Feye et al., 2016; Feye et al., 2016).  Data presented are the mean 
+ SEM from data obtained from 10 calves from each group on at least two separate 
occasions.  (P<0.05 for all asterisks) 
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Figure 3.2 Assessment of Salmonella lysis by leukocytes obtained from calves fed 
XPC compared to the control. Newborn dairy calves were fed daily doses of XPC for 
five weeks (Brewer et al., 2014a).  At various points during the five weeks of the study, 
approximately 4mL of whole blood was collected into an EDTA tube, of which 3mL was 
transferred into a microfuge tube and subjected to density gradient centrifugation (the other 
1mL was submitted for CBC analysis).  The erythrocyte fraction was then removed and 
120L of the buffy coat interface was collected and aliquoted into six separate tubes, to 
which 107 colony-forming units of Salmonella (approximate multiplicity of infection=100) 
were added and the tubes were incubated at 37oC.  After 1h, extracellular (i.e., non-invasive) 
bacteria were killed by the addition of 50g/mL gentamicin.  At 0, 1, 2, 4, 8, and 12 hrs post-
killing, leukocytes were centrifuged and the gentamicin-containing media was removed and 
replaced with 50L of phosphate-buffered saline containing 1% Triton which lyses the 
leukocytes.  Lysates were then plated on XLD agar that was incubated overnight at 37oC.  
The following day, black-centered colonies were enumerated and Salmonella survival/cell 
was calculated as number of recovered colonies/number of leukocytes per 20L blood 
(derived from the CBC analyses).  The strains used were S. Dublin SGI1 (Xiong et al., 2010) 
and S. Typhimurium LNWI (Wu et al., 2002).  Data presented are the mean + SEM from 
leukocytes obtained from 10 calves from each group on at least two separate occasions. 
(p<0.05 for all asterisks). 
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Figure 3.3 Persistence of the effect of XPC on hilA expression and invasiveness of 
Salmonella recovered from feces of naturally infected chickens fed XPC (or a Control 
diet) for ≥ 28 days. Salmonella were recovered from treatment-specific birds and then 
serially subjected to the invasion assays examining cell penetration and virulence gene 
expression.  Generations 1-4 represent Salmonella serially recovered from tissue culture 
studies while Generation 0 represents Salmonella directly recovered from birds. 
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4.1 Abstract 
 
Salmonella and E. coli O157:H7 are insidious problems for the beef industry.  
Asymptomatic fecal shedding of these pathogens contaminates the hide and carcass.  
Furthermore, Salmonella are unique in their ability to infiltrate lymph nodes leading to the 
post-harvest contamination of ground beef.  These contaminations yield the two most 
important food safety hazards associated with the consumption of beef.  Herein, we report the 
anti-Salmonella and anti-E. coli O157:H7 effects of a novel Saccharomyces cerevisiae 
fermentation prototype (PRT; NaturSafeTM) fed to feedlot cattle.  Cattle fed PRT were 
compared to those fed a combination of monensin, tylosin, and a direct-fed microbial- a 
standard conventional practice in the U.S. beef industry.  In this investigator-blinded study, 
1,495 feedlot heifers (300-400 kg) were fed PRT (n=747 heifers) or the standard industry diet 
(PC; n=748 heifers) without PRT for 125-146 days prior to slaughter.  At the abattoir, fecal 
swabs were obtained from 400 animals (n=200/group) and subjected to selective culture for 
enumerating Salmonella and E. coli O157:H7.  Additionally, subiliac lymph nodes were 
obtained from 400 carcasses for enumeration of Salmonella spp.  Salmonella isolated from 
the feces and lymph nodes were subjected to a virulence assay and some antibiotic 
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susceptibility and Salmonella serovar testing.  When compared to cattle that received PC, 
Salmonella fecal shedding, lymph node infiltration, virulence, and antibiotic resistances were 
significantly decreased in cattle fed PRT.  Additionally, PRT-fed cattle had a lower 
prevalence of certain Salmonella serovars (Newport, Typhimurium, and Dublin) and shed 
fewer E. coli O157:H7.  The decrease in Salmonella virulence was associated with a 
decreased expression of hilA, a genetic regulator of Salmonella invasion into eukaryotic cells.  
This study revealed that a proprietary Saccharomyces cerevisiae fermentation prototype 
inhibits the shedding, lymph node carriage, downstream virulence, and antibiotic resistance 
of Salmonella residing in cattle beyond the standard conventional practice that includes 
monensin, tylosin, and a direct-fed microbial.  Key words: Salmonella, cattle, Saccharomyces 
cerevisiae fermentation product 
 
4.2 Introduction 
Bovine-associated Salmonella are capable of causing clinical disease, but these 
Salmonella can also asymptomatically reside in the intestinal tract and lymph nodes of cattle.  
Both of these reservoirs create food safety hazards, especially the latter situation where 
lymph nodes serve as a protective conduit for Salmonella passage into ground beef (Brichta-
Harhay et al., 2012).  The intestines also serve as a reservoir for E. coli O157:H7, which is 
non-pathogenic in cattle but highly pathogenic in humans (Smith et al., 2014). 
Intestinal Salmonella and E. coli O157:H7 lead to surface contamination of beef, 
which can be mitigated by a number of different strategies at the abattoir (Soon et al., 2011).  
Lymph node infiltration, on the other hand, is problematic given the number of lymph nodes 
unavoidably co-harvested with ground beef and the covertness of the Salmonella within the 
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lymph nodes (Brichta-Harhay et al., 2012).  Concerns with Salmonella in the lymph nodes 
underscores the need for improving Salmonella prophylaxis either in the pre-harvest or post-
harvest setting.  Recent studies have demonstrated that soluble components present in 
Saccharomyces cerevisiae fermentation products (SCFP; SmartCare® and Original XPC™, 
Diamond V) eliminate Salmonella from the gastrointestinal tract of experimentally-infected 
calves (Brewer et al., 2014).  Specifically, SCFP (SmartCare and Original XPC) significantly 
reduced the intestinal burden and pathogenic effects of Salmonella in calves (Brewer et al., 
2014).  Because of these benefits, the anti-Salmonella effects of SCFP were examined in 
feedlot cattle naturally infected with Salmonella.  The aims of this study were to determine a 
broad range of effects of a proprietary S. cerevisiae fermentation prototype (PRT; 
NaturSafeTM) on Salmonella when fed to finishing cattle.  Specifically, fecal shedding, lymph 
node infiltration, downstream virulence, antibiotic resistance, and the prevalence of virulent 
Salmonella serotypes with a broad host range were determined.  The virulence aspect was 
examined, in part, because SCFP (EpiCor®, Embria Health Sciences) can increase intestinal 
butyrate production (Possemiers et al., 2013), and this short-chain fatty acid has been shown 
to inhibit Salmonella virulence mechanisms in vitro (Gantois et al., 2006).  The antibiotic 
resistances were examined since SCFP (Original XPC) can modulate the microbiome 
(Mullins et al., 2013; Price et al., 2010), which can alter the antibiograms of resident bacteria 
( Kirkup et al., 2004).  Additionally, we examined the effects of the SCFP on the shedding of 
E. coli O157:H7 since this microbe shares mammalian cell adhesion strategies with 
Salmonella (Rossez et al., 2015).  Comparisons were made to cattle fed a combination of 
monensin, tylosin, and a direct-fed microbial, which is a standard conventional practice in the 
U.S. beef industry. 
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4.3 Materials and Methods 
4.3.1 Animal Care and Study Design 
Heifers (n = 1,495; 300 – 400kg) were obtained from two sale barns (n = 438) and 
one backgrounding facility (n = 1,057) in Kansas in May of 2015.  Cattle were shipped to a 
commercial feedlot in Central Kansas and were provided water and hay ad libitum.  On day 1 
post-arrival, heifers were individually weighed, identified, implanted, and vaccinated using 
standard procedures at the feedlot.  Heifers were then randomly assigned into pens in groups 
of five until each pen reached its optimal capacity (~75 animals) based on bunk space and the 
area of the pen (14.4 inches of bunk space and 231 square feet of pen space per animal).  
Two adjacent pens were designated as a single block and 10 blocks were created 
within the feedlot.  Pens of heifers in each block were provided either a diet that contained a 
combination of standard industry technologies (PC), including monensin (Rumensin, Elanco 
Animal Health, 300 mg/head/day), tylosin (Tylovet, Huvepharma, 90 mg/head/day) and a 
direct-fed microbial (Bovamine Defend, Nutrition Physiology Company, 50 mg/head/day); 
or a diet containing 18 gm/head/day of a S. cerevisiae fermentation prototype (PRT; 
NaturSafeTM, Diamond V) without monensin, tylosin, or the direct-fed microbial.  Heifers 
received three step-up diets prior to their final finishing diet (Table 4.1).  All treatment feed 
additives were stored under manufacturer-recommend conditions and added to the final 
ration using a micro-ingredient weight machine (Micro Beef Technologies, Amarillo, TX).   
During the study, heifers were monitored for illness and treated as per 
recommendations by a veterinarian.  Heifers that responded to treatment were returned to the 
40 
 
study while non-responders were removed from the study.  Morbidities and mortalities were 
indistinct between the two groups (data not shown). 
At the conclusion of the study, heifers were shipped 145 miles to a commercial 
abattoir on two separate dates that were three weeks apart.  These shipping dates 
corresponded to 125 and 146 days on study for the first and second groups, respectively.  An 
equal number of pens per treatment group were shipped on each date (n = 5 per treatment).  
Shipments and carcass processing occurred on a pen-by-pen basis.  
4.3.2 Sample Collection at the Abattoir 
Individual animal numbers were not carried through the entire harvest process.  Only 
the first and last animal within a pen was tagged with a lot identification tag that 
corresponded back to the pen number.  Since individual identification was not maintained, it 
was not possible to keep track of which animals were sampled.  As a result, lymph node and 
fecal samples may or may not have been collected from the same animals.  
Fecal swabs were collected on the rail from 20 animals per pen (replicate).  Samples 
were collected from every third or fourth animal within a replicate.  Fecal samples were 
collected using a 3M-sponge stick pre-saturated with buffered peptone water.  Sponge sticks 
were inserted into the rectum (recto-anal junction) to collect the sample.  After the sample 
was collected, the sponge was placed into a pre-labeled bag containing buffered peptone 
water.  The bag was closed and placed into a cooler. 
Subiliac lymph nodes and the surrounding tissue were collected post-evisceration.  
Sample collection began with the first carcass in each replicate and continued with every 
third or fourth carcass within that replicate.  Lymph nodes were placed into pre-labeled 
Whirlpak bags.  The bags were closed and placed in a cooler.  Fecal swabs and lymph node 
samples were then immediately shipped on ice to Iowa State University College of 
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Veterinary Medicine (Ames, Iowa, USA) for microbiological analyses. 
4.3.3 Assessment of Salmonella Fecal Load and Lymph Node Infiltration  
Salmonella spp. were enumerated from every fecal swab sample and lymph node 
collected (20 per pen; 200 per treatment) using selective agar (XLD) methods described by 
Brewer et al. (Brewer et al., 2014).  Approximately 0.3 gm of feces or lymph node were 
collected on a sterile cotton swab and then aseptically transferred into 10mL Lennox broth 
and an aliquot of the broth was immediately plated on XLD agar, incubated overnight at 
37oC, and subjected to enumeration by manual counting of black-centered colonies the next 
day.  Load was then determined as (colonies recovered) x (the dilution factor) / gm of feces 
or lymph node.  Prevalence was calculated as percent of heifers harboring any Salmonella 
and was compiled across pens within a treatment group. 
4.3.4 Assessment of E. coli O157:H7 in the Feces 
E. coli O157:H7 was enumerated in 100 of the swab samples (five per pen; 50 swab 
samples per treatment) using selective media (Sorbitol-MacConkey agar) and a PCR 
targeting E. coli O157:H7 virulence genes as per Sharma and Casey (Sharma and Casey, 
2014).  Approximately 0.3 gm of feces were transferred into enrichment broth (Sharma and 
Casey et al., 2014) and an aliquot of the broth was plated on sorbitol-MacConkey agar, 
incubated overnight at 37oC, and subjected to enumeration by manual counting of non-
fermenting colonies the next day.  From each pen-specific set of agar plates, 96 colonies 
were selected and subjected to the PCR targeting E. coli O157:H7 virulence genes.  Load 
was then determined as (colonies recovered x the dilution factor x the percent of colonies 
yielding an E. coli O157H7-specific amplicon within the pen) / gm of feces.  Prevalence was 
calculated as percent of heifers harboring any E. coli O157:H7 within a pen, and was 
compiled across pens within a treatment group.    
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4.3.5 Assessment of Tissue Culture Invasiveness by Salmonella Recovered from 
Cattle  
Approximately 50% of the recovered Salmonella were subjected to a standard 
antibiotic protection-based tissue culture invasion assay (Giannella et al., 1973) adapted for 
use with both antibiotic-susceptible and antibiotic-resistant Salmonella (Carlson et al., 2000).  
Colonies were collected en masse, on a pen-by-pen basis, into nutrient broth and then 
immediately incubated for 1 hr with HEp-2 tissue culture cells at 37oC.  Bacteria were 
recovered from inside tissue culture cells via cell lysis, incubated on XLD agar overnight at 
37oC, and enumerated the next day.  Percent invasion was determined as (number of black-
centered colonies recovered from inside cells / number of colonies added to cells) x 100. 
4.3.6 Assessment of Virulence Gene Expression in Salmonella Isolated from 
Cattle 
In order to correlate the virulence of Salmonella recovered from cattle with gene 
expression events in the pathogen, approximately 10% of the recovered Salmonella isolates 
were subjected to an assay that quantitates the expression of hilA (a key regulator of 
Salmonella invasion genes; (Bajaj et al., 1995).  RNA was extracted from the isolates that 
were collected en masse on a pen-by-pen basis, and then subjected to a semi-quantitative RT-
PCR targeting the hilA transcript (Carlson et al., 2007) 
4.3.7 Assessment of Antibiotic Resistance in Salmonella Recovered from Cattle 
Approximately 20% of the recovered Salmonella were individually subjected to 
micro-broth assays with individual antibiotics (florfenicol, ceftiofur, and enrofloxacin) at 
breakpoint concentrations (Institute, 2015).  Colonies that grew in the breakpoint 
concentrations were deemed to be resistant.  Percent resistant were then determined as 
(number of resistant colonies / number of colonies examined) x 100.  Data were compared 
across pens and between groups.  
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4.3.8 Assessment of the Presence of Three Important Salmonella Serotypes in the 
Samples 
Nearly 20% of the recovered Salmonella were individually subjected to PCR assays 
that detect the presence of genes related to Dublin (Akiba et al., 2011), Typhimurium (Akiba 
et al., 2011), and Newport (Cao et al., 2013) serotypes.  Colonies yielding a specific PCR 
amplicon(s) were deemed to belong to the ascribed serotype.  Percent belonging to the 
serotype were then determined as (number of colonies yielding a specific amplicon / number 
of colonies examined) x 100.  Data were compared across pens and between groups. 
4.3.9 Statistical Analyses 
Statistical comparisons were made using an analysis of variance with Tukey’s ad hoc 
test for multiple comparisons (GraphPad Prism, Version 6, La Jolla, CA).  Significant 
differences were defined at P ≤ 0.05.   
 
4.4 Results 
4.4.1 Assessment of Salmonella Fecal Shedding in Cattle 
Salmonella can be a potential pathogen source for humans who consume improperly 
cooked beef.  Carcasses can become exposed to Salmonella through fecal contamination 
during processing.  In this study, fecal shedding of Salmonella was evaluated in 200 heifers 
postmortem from each treatment group.  As shown in Figure 4.1a, fecal shedding of 
Salmonella was significantly less (P < 0.05) in cattle fed PRT (105 versus 405 CFU/gm of 
feces, respectively).  The relative prevalence of fecal shedding was significantly less (P < 
0.05) in heifers fed PRT (6 versus 13%, respectively) as per Figure 4.1b. 
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4.4.2 Assessment of Lymph Node Infiltration by Salmonella 
Since Salmonella lymph node carriage can be a source of contamination of ground 
beef (Brichta-Harhay et al., 2008), Salmonella load was determined in the subiliac lymph 
nodes of 200 carcasses from each treatment group.  As shown in Figure 4.2a, lymph node 
infiltration was significantly less (P < 0.05) in carcasses from heifers fed PRT (902 versus 
6,642 CFU/gm of lymph node, respectively).  The percent of Salmonella-bearing lymph 
nodes was significantly less (P < 0.05) in carcasses from heifers fed PRT (4 versus 14%, 
respectively) as per Figure 4.2b. 
4.4.3 Determination of E. coli O157:H7 in the Feces of Cattle  
To determine if PRT had an effect on the presence of E. coli O157:H7 in the feces of 
the heifers, fecal samples (100 per treatment group) were quantitatively examined for the 
presence of this critical foodborne pathogen.  As shown in Figure 4.3a, heifers fed PRT had a 
statistically lower (P < 0.05) E. coli O157:H7 fecal load than heifers fed PC (52 versus 122 
CFU/gm of feces, respectively).  Figure 4.3b reveals a decreased prevalence (P < 0.05) of E. 
coli O157:H7 in heifers fed PRT when compared to those receiving the PC diet (37 versus 
57%, respectively). 
4.4.4 Assessment of the Virulence of Salmonella Recovered from Cattle 
In order to compare the virulence of Salmonella recovered from cattle, the isolates 
were subjected to an assay that predicts the ability of Salmonella to invade gut epithelial 
cells, which is a hallmark of Salmonella virulence (Millemann, 1998).  The effects of PRT on 
virulence were examined due to the ability of SCFP to increase butyrate in the intestine 
(Possemiers et al., 2013).  Research has shown that butyrate can decrease the Salmonella 
invasion gene (hilA) expression in vitro (Gantois et al., 2006), which results in the decreased 
ability of Salmonella to invade cells.  In the current study, invasiveness of Salmonella was 
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significantly less (P < 0.05) in Salmonella recovered from the feces and lymph nodes of 
cattle fed PRT (Figure 4.4).  This decrease in invasiveness coincided with a decrease in the 
expression of hilA (Figure 4.5), a major regulator of Salmonella virulence for mammalian 
hosts (Bajaj et al., 1995). 
4.4.5 Assessment of the Antibiotic Resistance of Salmonella Recovered from 
Cattle 
The antibiotic resistance of Salmonella in lymph nodes and fecal samples were 
examined since SCFP can modulate the microbiome (Mullins et al., 2013; Price et al., 2010), 
which can alter the antibiograms of resident bacteria (Benjamin C. Kirkup, 2004).  To assess 
the possibility that PRT inhibits antibiotic resistant Salmonella or induces the expulsion of 
antibiotic resistance elements from Salmonella, isolates recovered from cattle were subjected 
to an antibiotic susceptibility assay that utilized three individual antibiotics (ceftiofur, 
enrofloxacin, and florfenicol).  These three antibiotics were chosen given their extended 
spectra and importance in bovine therapeutics.  Additionally, two of the three antibiotics 
tested (ceftiofur and enrofloxacin) have counterparts important for human therapeutics 
(ceftriaxone and ciprofloxacin, respectively). 
Figure 4.6 reveals a decrease in the prevalence of resistant (P < 0.05) Salmonella 
recovered from heifers fed PRT for all three antibiotics.  This figure represents isolates from 
both feces and lymph nodes.  It is of note that resistance of these antibiotics was, in general, 
more prevalent in the fecal isolates when compared to the lymph node isolates. 
4.4.6 Assessment of the Presence of Three Important Salmonella Serotypes in the 
Samples 
Salmonella isolates recovered from the feces or lymph nodes of cattle were subjected 
to PCR assays targeting three serotypes (Dublin, Newport, and Typhimurium).  As shown in 
Figure 4.7, the prevalence of two of these serovars was diminished in heifers fed PRT, 
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regardless of the source of the isolates.  No S. Dublin were isolated from feces and only one 
colony of S. Dublin was isolated from lymph nodes.  Thus, statistical evaluations are not 
presented for this minor subsection of the study. 
 
4.5 Discussion 
Salmonella and E. coli O157:H7 are insidious problems for the beef industry and 
represent critical food safety hazards.  Salmonella and E. coli O157:H7 can be shed in fecal 
material that can contaminate the carcass during processing.  Salmonella is also harbored in 
the lymph nodes, which can lead to contamination of ground beef.  Therefore, identifying 
mitigation strategies for both pathogens is needed especially considering the covert nature of 
Salmonella lymph node infiltration (Brichta-Harhay et al., 2008). 
In this study, the anti-Salmonella and anti-E. coli O157:H7 effects of NaturSafeTM 
(PRT) were examined and two critical indicators of Salmonella contamination (fecal 
shedding and lymph node infiltration) were significantly reduced by NaturSafeTM.  In this 
study, heifers fed PC shed a higher number of Salmonella and E. coli O157:H7 and had more 
Salmonella present in the lymph nodes, which ultimately increases the risk of pathogen 
transmission to humans that ingest beef.  There are currently no other research studies 
looking at the effects of NaturSafeTM on pathogens in beef cattle but there are studies 
examining the effects of other SCFP products on pathogen load.  These results described 
herein are consistent with a previous study in which SCFP (SmartCare and Original XPC) 
reduced intestinal colonization in pre-ruminant calves (Brewer et al., 2014a), which is 
possibly due to macrophage-associated clearance of the pathogen.  In another study, 
cannulated beef heifers supplemented with SCFP (Original XP®, Diamond V) had less E. coli 
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O157:H7 colonizing the recto-anal junction after being challenged with E. coli O157:H7 
(Liou et al., 2009).  Therefore, SCFP products seem to minimize the levels of Salmonella and 
E. coli O157:H7 in cattle. 
Other significant and unique findings in this study were the reduction in virulence and 
antibiotic resistance in Salmonella recovered from heifers fed PRT. Reduced virulence was 
detected by diminished tissue culture invasion with a concomitant reduction in the expression 
of hilA (Bajaj et al., 1995).  It is unclear how virulence was mitigated by feeding this SCFP 
prototype.  However, previous studies revealed that SCFP (EpiCor) increases the 
gastrointestinal production of butyrate (Possemiers et al., 2013), a putative repressor of hilA 
expression (Durant et al., 2000).  Regardless of the mechanism underlying this effect, the 
observed magnitude of decreased invasiveness is likely to increase the infectious dose of 
Salmonella for a human as evidenced by our prior study, in which this level of diminished 
invasiveness altered the murine LD50 approximately 5-fold (Carlson et al., 2000).   
4.6 Conclusions 
In summary, NaturSafeTM-fed feedlot heifers were significantly less likely to shed 
Salmonella and harbor this pathogen in the lymph nodes.  The anti-shedding effect of 
NaturSafeTM was also observed for E. coli O157:H7.  Additionally, NaturSafeTM reduced the 
virulence and antibiotic resistance of recovered Salmonella.  Ultimately, these beneficial 
effects will have a marked positive effect on food safety in the beef industry.  Future 
mechanistic studies are warranted to uncover the molecular bases for these effects. 
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4.7 Tables and Figures 
Table 4.1 Composition of Diets 
Ingredient 
% of dry 
matter 
Starter Ration 2 Ration 3 Finisher 
Steam-flaked 
corn 
30.2 45.8 58.6 66.1 
Wet distiller’s 
grain 
22.2 19.5 18.0 18.0 
Alfalfa hay 38.0 25.0 13.0 - 
Corn stalks - - - 4.0 
Corn silage 7.0 7.0 5.0 4.0 
Tallow - - 1.5 2.9 
Supplement
1,2
 
2.6 2.7 3.9 5.0 
1
Control rations were formulated to provide 300 mg of monensin (Elanco Animal 
Health, Greenfield, IN), 90 mg of tylosin (Zoetis Animal Health, Florham, NJ), 0.5 mg of 
melengestrol acetate (Zoetis Animal Health), and 50 gm Bovamine Defend (Nutrition 
Physiology Company, Overland Park, KS) per heifer daily throughout the study, and 250 
mg of ractopamine hydrochloride (Zoetis Animal Health) per heifer daily during the last 28 
days on feed. 
2
Rations containing PRT were formulated to provide 18 gm of a Saccharomyces 
cerevisiae fermentation prototype (NaturSafeTM; Diamond V, Cedar Rapids, IA) and 0.5 
mg of melengestrol acetate (Zoetis Animal Health) per heifer daily throughout the study, 
and 250 mg of ractopamine hydrochloride (Zoetis Animal Health) per heifer daily during 
the last 28 days on feed. 
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Figure 4.1 Salmonella fecal load in heifers fed PRT (NaturSafeTM) or PC. The PC diet 
contained monensin (Elanco Animal Health), tylosin (Huvepharma) and a direct-fed 
microbial (Nutrition Physiology Company).  The PRT diet contained Saccharomyces 
cerevisiae fermentation prototype (NaturSafeTM; Diamond V) and no monensin, tylosin, or a 
direct-fed microbial.  Data represent the mean + SEM for measurements on 200 heifers in 
each group.  *P < 0.05 versus Control. 
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Figure 4.2 Prevalence of Salmonella fecal shedding in heifers fed PRT or PC. The PC 
diet contained monensin (Elanco Animal Health), tylosin (Huvepharma) and a direct-fed 
microbial (Nutrition Physiology Company).  The PRT diet contained Saccharomyces 
cerevisiae fermentation prototype (NaturSafeTM; Diamond V) and no monensin, tylosin, or a 
direct-fed microbial.  Data represent the mean + SEM for the qualitative prevalence (% of 
heifers shedding Salmonella) across pens in each group.  *P < 0.05 versus Control. 
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Figure 4.3 Assessment of Lymph node infiltration by Salmonella in heifers fed PRT 
or PC. The PC diet contained monensin (Elanco Animal Health), tylosin (Huvepharma) and 
a direct-fed microbial (Nutrition Physiology Company).  The PRT diet contained 
Saccharomyces cerevisiae fermentation prototype (NaturSafeTM; Diamond V) and no 
monensin, tylosin, or a direct-fed microbial.  Data represent the mean + SEM for 
measurements on 200 heifers in each group.  *P < 0.05 versus Control. 
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Figure 4.4 Assessment of the Prevalence of Salmonella lymph node infiltration in 
heifers fed PRT or PC. The PC diet contained monensin (Elanco Animal Health), tylosin 
(Huvepharma) and a direct-fed microbial (Nutrition Physiology Company).  The PRT diet 
contained Saccharomyces cerevisiae fermentation prototype (NaturSafeTM; Diamond V) and 
no monensin, tylosin, or a direct-fed microbial.  Data represent the mean + SEM for the 
qualitative prevalence (% of heifers shedding Salmonella) across pens in each group.  *P < 
0.05 versus Control 
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Figure 4.5 E. coli O157:H7 fecal load in heifers fed PRT or PC. The PC diet contained 
monensin (Elanco Animal Health), tylosin (Huvepharma) and a direct-fed microbial 
(Nutrition Physiology Company).  The PRT diet contained Saccharomyces cerevisiae 
fermentation prototype (NaturSafeTM; Diamond V) and no monensin, tylosin, or a direct-fed 
microbial.  Data represent the mean + SEM for measurements on 50 heifers in each group.  
*P < 0.05 versus Control. 
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Figure 4.6 Prevalence of E. coli O157:H7 fecal shedding in heifers fed PRT or PC. 
The PC diet contained monensin (Elanco Animal Health), tylosin (Huvepharma) and a direct-
fed microbial (Nutrition Physiology Company).  The PRT diet contained Saccharomyces 
cerevisiae fermentation prototype (NaturSafeTM; Diamond V) and no monensin, tylosin, or a 
direct-fed microbial.  Data represent the mean + SEM for the qualitative prevalence (% of 
heifers shedding E. coli O157:H7) across pens in each group.  *P < 0.05 versus Control. 
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Figure 4.7 Tissue culture invasiveness of Salmonella recovered from the feces or 
lymph nodes of heifers fed PRT or PC.  The PC diet contained monensin (Elanco Animal 
Health), tylosin (Huvepharma) and a direct-fed microbial (Nutrition Physiology Company).  
The PRT diet contained Saccharomyces cerevisiae fermentation prototype (NaturSafeTM; 
Diamond V) and no monensin, tylosin, or a direct-fed microbial.  Data represent the mean + 
SEM for group measurements on Salmonella recovered from 200 heifers in each group.  *P < 
0.05 versus Control. 
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Figure 4.8 Semi-quantitation of hilA expression of Salmonella recovered from the 
feces and lymph nodes of heifers fed PRT or PC. The PC diet contained monensin (Elanco 
Animal Health), tylosin (Huvepharma) and a direct-fed microbial (Nutrition Physiology 
Company).  The PRT diet contained Saccharomyces cerevisiae fermentation prototype 
(NaturSafeTM; Diamond V) and no monensin, tylosin, or a direct-fed microbial.  Data 
represent the mean + SEM for pooled group measurements on Salmonella recovered from 
feces or lymph nodes.  *P < 0.05 versus Control. 
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Figure 4.9 Prevalence of antibiotic resistant Salmonella recovered from the feces and 
lymph nodes of heifers fed PRT or PC. The PC diet contained monensin (Elanco Animal 
Health), tylosin (Huvepharma) and a direct-fed microbial (Nutrition Physiology Company).  
The PRT diet contained Saccharomyces cerevisiae fermentation prototype (NaturSafeTM; 
Diamond V) and no monensin, tylosin, or a direct-fed microbial.  Data represent the mean + 
SEM for pooled group measurements on Salmonella recovered from feces and lymph nodes.  
*P < 0.05 versus Control. 
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Figure 4.10 Prevalence of certain Salmonella serotypes recovered from the feces and 
lymph nodes of heifers fed PRT or PC.  The PC diet contained monensin (Elanco Animal 
Health), tylosin (Huvepharma) and a direct-fed microbial (Nutrition Physiology Company).  
The PRT diet contained Saccharomyces cerevisiae fermentation prototype (NaturSafeTM; 
Diamond V) and no monensin, tylosin, or a direct-fed microbial.  Data represent the mean + 
SEM for group measurements on Salmonella recovered from feces and lymph nodes.  *P < 
0.05 versus Control. 
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CHAPTER 5.   INHIBITION OF THE VIRULENCE, ANTIBIOTIC RESISTANCE, 
AND FECAL SHEDDING OF MULTIPLE ANTIBIOTIC-RESISTANT 
SALMONELLA TYPHIMURIUM IN BROILERS FED ORIGINAL XPC™ 
K. M. Feye1, K. L. Anderson1, M. F. Scott2, D. R. McIntyre2, and S. A. Carlson1 
 
Modified from manuscript: Poultry Science, 2016 
1. Department of Biomedical Sciences, Iowa State University, Ames, Iowa, USA 
2. Diamond V, Cedar Rapids, Iowa, USA  
5.1 Abstract 
 Salmonella carriage is an insidious problem for the poultry industry.  While most 
Salmonella serotypes are avirulent in poultry, this bacterium can contaminate chicken meat 
during processing and leads to one of the most important food safety hazards.  In this study, 
we examined the anti-Salmonella effects of Diamond V Original XPCTM (XPC) included in 
the finisher diet fed to commercial broilers.  On three occasions between D1 and D20, 
broilers were experimentally infected with multiple antibiotic-resistant Salmonella 
Typhimurium.  After confirming that the chicks were shedding Salmonella in the feces on 
D21, broiler chicks were fed a diet containing XPC (n=57 birds; 1.25kg/MT) or an XPC-free 
Control diet (CON) (n=57 birds) to Day 49.  Fecal samples were obtained weekly and 
subjected to selective culture for enumerating and determining the antibiotic resistance of the 
Salmonella.  Salmonella isolates were then subjected to an in vitro virulence assay, which 
predicts the ability of Salmonella to cause illness in a mammalian host.  Broilers were 
euthanized on D49 and a segment of the large intestine was removed and subjected to the 
same assays used for the fecal samples.  When compared to the birds fed the CON diet, 
Salmonella fecal shedding, virulence, and antibiotic resistance were significantly decreased 
in birds fed XPC (5-fold, 7.5-fold, 6-fold, and 5.3-fold decreases, respectively).  Birds fed 
XPC exhibited heavier body weight (BW) and greater BW gains than those fed the CON diet.  
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The decrease in virulence was associated with a decreased expression of a genetic regulator 
of Salmonella invasion into eukaryotic cells (hilA), while the decrease in antibiotic resistance 
was due to a loss of an integron (SGI1) from the input strain.  This study revealed that 
Original XPC inhibits the shedding, downstream virulence, and antibiotic resistance of 
Salmonella residing in broilers.   
 
5.2 Introduction 
Most Salmonella, except for serovars Pullorum and Gallinarum (Wilson et al., 2000) 
and possibly other strains [e.g., S. Kentucky (Ogunleye et al., 2015)], are capable of 
asymptomatically residing in the intestinal tracts of poultry.  Many Salmonella serotypes can 
be acquired by the fecal-oral route and then be shed into the feces (Traub-Dargatz et al., 
2006).  Many birds can be infected since the ingestion, colonization, and shedding events 
typically cause no harm to the bird and since Salmonella is ubiquitous in the environment.  
Salmonella can therefore contaminate poultry meat prior to (from fecal shedding) or during 
processing (from intestinal leakage), resulting in one of the leading causes of Salmonella 
infections in humans (CDC, 2016). 
Recent studies have shown that the fermentation metabolites of Original XPCTM 
(XPC, Diamond V, Cedar Rapids, IA), and earlier product derivatives, enhance poultry 
health and performance (Jensen et al., 2008) by promoting immune functions such as 
inducing the production of anti-viral antibodies, enhancing serum lysozyme activity, 
increasing IgM, increasing T-lymphocytes, and increasing secretory IgA (Gao et al., 2009; 
Gao et al., 2008).  Additional studies revealed that an XPC-like technology, available for use 
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in humans (EpiCor®, Embria Health Sciences), increases NK cell activity and serum 
antioxidant protection (Jensen et al., 2011). 
Furthermore, Salmonella suppressing effects have been shown in the gastrointestinal 
tract of the bird (Al-Homidan and Fahmy, 2007; Ibukic et al., 2012).  Specifically, XPC 
fostered a significant reduction in both numbers and prevalence of Salmonella Heidelberg in 
broilers (Horface, 2015).  These anti-Salmonella effects (decreased load and prevalence) 
have also been observed in calves fed XPC, where the product also protected the animal from 
various pathophysiologic consequences of the pathogen (Brewer et al., 2014).  
Because of these potential food safety benefits, a study was designed to further 
examine the anti-Salmonella Typhimurium effects associated with XPC in chickens.  The 
objectives of this study were to determine the effects of XPC on a multiple antibiotic 
resistant Salmonella Typhimurium in broiler chickens experimentally infected with the 
microbe: specifically, fecal shedding, large intestinal carriage, downstream virulence, and 
antibiotic resistance.  The virulence aspect was examined since an XPC-like technology 
(EpiCor®, Embria Health Sciences) has been shown to increase intestinal butyrate 
production (Possemiers et al., 2013), and this short-chain fatty acid has been shown to inhibit 
Salmonella virulence mechanisms in vitro by down regulating 17 genes (including hilA) in 
the pathogenicity island of Salmonella (Gantois et al., 2006).  This repression in hilA was 
most evident in S. Enteriditis where a six-fold decrease in expression was observed through 
an unknown mechanism (Gantois et al., 2006).  We also pursued the virulence studies since 
XPC can apparently suppress Salmonella virulence in cattle (Brewer et al., 2014). 
Antibiotic resistance was examined since XPC can modulate the microbiome 
(Mullins et al., 2006; Price et al., 2010), which can alter the antibiograms of resident bacteria 
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(Kirkup and Riley et al., 2004).  To assess the parameters, birds were experimentally infected 
with integron-bearing multi-resistant Salmonella and fed XPC after which quantity, 
prevalence, virulence, and antibiotic resistance of Salmonella was examined.  Integron-
mediated resistance was chosen since our previous studies revealed that intestinal factors 
facilitate the expulsion of integrons from Salmonella (Brewer, 2013).  Comparisons were 
made to Salmonella recovered from experimentally-infected broilers fed a standard 
commercial diet. 
 
5.3 Materials and Methods 
5.3.1 Experimental Design and Husbandry 
An experiment was conducted at Iowa State University (Ames, IA) using day-old 
Cobb broiler chicks that were obtained from Welp Hatchery (Bancroft, Iowa).  Three 
separate and independent replications of this experiment were conducted using a total of 50 
chicks per experiment (25 per treatment group), resulting in a total of 75 chicks per 
treatment.  On D0, birds were housed in a BL-2 facility in pens (0.09 m2; 10 birds/pen) 
within rooms that were both humidity (~40 %) and temperature controlled (35oC for three 
days then 28-31oC for the remainder of the study).  On D14, birds were moved to elevated 
Tenderfoot-type decks (13.4 m2 per treatment group) for the remainder of each experiment.  
Feed was provided in a metal feed trough and water through a bell drinker. 
All birds were fed a non-medicated starter diet (24 % crude protein; Tractor Supply 
Company, Brentwood, TN) from D0 to 21.  Birds were then randomly assigned on D21 to 
one of two feed treatment groups: 1) finisher Control diet only (CON), or 2) finisher diet that 
contained 1.25 kg/MT Original XPCTM (XPC; Diamond V, Cedar Rapids, IA).  From D21 to 
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49, the basal diet was a non-medicated finisher diet (18-19 % crude protein; Solon Feed Mill, 
Solon, IA) and birds were allowed ad libitum access to feed and water.  Photoperiod 
consisted of 12 h light and 12 h dark.  All birds were individually weighed on D21 and then 
again at the end of the study on D49. 
Each room held one treatment group to avoid inadvertently administering the wrong 
treatment within a room.  Throughout the three consecutive studies, treatment groups were 
alternated in the two different rooms to avoid a potential room effect.  The investigators at 
Iowa State University were blinded as to which birds received the CON or XPC diet during 
the entire study.  The protocol used in these experiments was approved by the Institutional 
Animal Care and Use Committee at Iowa State University. 
5.3.2 Salmonella Challenge 
All birds were confirmed to be Salmonella-free by fecal culture upon arrival.  
Specifically, 1 to 5 g of freshly voided feces from each chick was diluted in 10 mL of 
Lennox L broth (Invitrogen, Carlsbad, CA).  After settling for 1-2 hrs at room temperature, 
an aliquot (100 L) of this mixture was streaked onto and then incubated overnight at 37oC 
on Xylose Lysine Deoxycholate (XLD) agar (Fisher Scientific, Pittsburgh, PA) that is 
selective for Salmonella which appear as white colonies with black centers (Anderson et al., 
2015).  All pre-infection fecal samples were free of Salmonella.   
On D2, 9, and 16, birds were orally inoculated with Salmonella Typhimurium strain 
LNWI (Wu et al., 2002; Anderson et al., 2015).  The dose increased from 2 x 108 CFU/bird 
on D2 (Anderson et al., 2015) to 4 x 108 CFU/bird on D9 to 8 x 108 CFU/bird on D16 and 
this procedure was done to maximize the likelihood of large intestinal carriage.  The 
Salmonella inoculum was prepared and dosed as previously reported (Anderson et al., 2015; 
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Xiong et al., 2010; Xiong et al., 2013; Xiong et al., 2012).  The inoculum was slowly 
introduced into the mouth of each bird using a pipette tip.  Previous studies revealed that 
Salmonella is viable after incubation with either XPC (at the concentration equivalent to the 
dose used in this study) or the CON treatment (Anderson et al., 2015).  
5.3.3 Assessment of Salmonella Fecal Shedding Prior to Treatments 
On D6, 13, and 20, 1 to 5 g of freshly voided feces from each bird was diluted in 10 
mL of Lennox L broth (Invitrogen, Carlsbad, CA).  After settling for 1-2h at room 
temperature, an aliquot (100 L) of this mixture was streaked onto and then incubated 
overnight at 37oC on XLD agar.  On D7 and 14, fecal samples were examined for the 
qualitative presence of Salmonella colonies on XLD agar.  On D21, Salmonella were 
enumerated on XLD agar and shedding was determined quantitatively as number of colonies 
x 100 (i.e., the dilution factor) divided by the grams of feces in the sample.  Any non-
shedding individual birds (as determined by fecal culture, n=6 per group per each of the three 
separate trials) were euthanized and removed from the study on D21.  The remaining birds 
were assigned to either treatment group based on body weight and Salmonella shedding, 
using a serpentine assignment format that mathematically redistributes birds in order to 
prevent a weight bias between groups.  Specifically, each bird was ranked based on weight 
and the bird with the lowest weight was grouped (e.g., Treatment Group A) with the bird 
with the highest weight; the bird with the second lowest weight was placed in the other group 
(Treatment Group B) along with the bird with the second highest weight; the bird with the 
third lowest weight was placed in Group A along with the bird with the third highest weight; 
the bird with the fourth lowest weight was placed in Group B along with the bird with the 
fourth highest weight; etc.  As an illustrative example using 36 birds segregated into two 
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treatment groups (either XPC or CON), the following body weight-based rankings would be 
used in each group: Treatment Group A, birds 1, 36, 3, 34, 5, 32, 7, 30, 9, 28, 11, 26, 13, 24, 
15, 22, 17, and 21; Treatment Group B, birds 2, 35, 4, 33, 6, 31, 8, 29, 10, 27, 12, 25, 14, 23, 
16, 21, 18, and 19.  Fecal shedding was also factored into the assignments for birds with 
identical weights or when an odd number of birds were available for segregation into the two 
groups.  That is, the fecal shedding data was considered, when necessary, in order to make 
the average fecal shedding equivalent between the groups. 
5.3.4 Assessment of Salmonella Shedding During Treatments 
On D21, treatments began for each group of birds (n=19 to 22 per group after 
removing non-shedders in each experiment).  On D28, 35, and 42, approximately 0.5 g of 
freshly voided feces (from each bird) was briefly vortexed in 10 mL of Lennox L broth 
(Invitrogen, Carlsbad, CA).  An aliquot of this mixture (100 L) was incubated overnight at 
37oC on XLD agar.  The following day white colonies with black centers were enumerated 
and CFU/g of feces was calculated based on a dilution factor equal to 100. 
5.3.5 Assessment of Large Intestinal Carriage by Salmonella  
On D49, all remaining birds were euthanized and a 5 cm section (approximately 3g) 
of distal intestine (between the cloaca and ceca) was aseptically removed from each bird and 
cut longitudinally.  Each section was placed in 10 mL Lennox L broth (Invitrogen, Carlsbad, 
CA) and briefly vortexed to dislodge the Salmonella.  An aliquot (100 L) of this mixture 
was then dispersed onto XLD agar plates that were incubated overnight at 37oC.  The 
following day, white colonies with black centers were enumerated and CFU/g of intestine 
was calculated based on a dilution factor equal to 100. 
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5.3.6 Assessment of the Invasiveness of Salmonella Recovered from Broiler 
Chickens 
On D21, 28, 35, 42, and 49, Salmonella recovered from broiler chickens were 
subjected to a mammalian tissue culture invasion assay.  After enumeration of colonies on 
XLD agar plates, approximately 30% of recovered colonies were immediately inoculated en 
masse into LB broth that was used in a standard gentamicin protection-based invasion assay 
using Human Epithelial Type 2 cells (Carlson et al., 2007; Carlson et al., 2000), with a 
multiplicity of infection equal to at least one.  Bacteria were allowed to adhere and invade 
tissue culture cells for 1 h, after which the extracellular (i.e., non-invasive) were killed with 
50g/ml gentamicin.  Tissue culture cells were then lysed with 1% Triton and the lysates 
were plated on XLD agar and grown overnight at 37oC.  The next day, colonies were counted 
and percent invasion was calculated as 100 x (number of Salmonella recovered from tissue 
culture wells/number of Salmonella incubated with tissue culture wells).  Invasion assays 
were performed in triplicate for both groups (XPC and CON) in each of the three separate 
experiments. 
5.3.7 Assessment of Invasion Gene Expression in Salmonella Recovered from 
Broiler Chickens 
Approximately 20% of Salmonella recovered from the birds were subjected to a semi-
quantitative RT-PCR that assesses the expression of hilA (Carlson et al., 2007), the global 
regulator of Salmonella invasion (Bajaj et al., 1995).  RNA was isolated and subjected to the 
semi-quantitative RT-PCR assay in which the number of PCR cycles (5 to 40) required to 
visualize an amplicon on agarose gel electrophoresis is documented (Carlson et al., 2007).    
5.3.7.1 RNA Isolation 
RNA was isolated from a group of colonies (n>40 colonies) picked directly from 
XLD plates and placed into PBS.  RNA was isolated using the RNEasy kit (Qiagen) as per 
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the manufacturer’s protocol.    
5.3.7.2 Semi-Quantitative RT-PCR 
RNA (50ng/assay) was subjected to the semi-quantitative RT-PCR assay in which the 
number of PCR cycles (5 to 40) required to visualize an amplicon on agarose gel 
electrophoresis is documented (Carlson et al., 2007).  PCR conditions and the hilA primers 
are described previously (Carlson et al., 2007).  The rpoS primers are 5’-
ATGAGTCAGAATACGCTGAA-3’ and 5’-TTACTCGCGGAACAGCGCTT-3’, 
representing the forward and reverse primers, respectively. 
5.3.7.3 Gene Analysis and Expression 
Subsets of reactions are removed every five cycles and resolved on 2% agarose gels 
run for 30 min., and amplicons are visualized under UV light.  Expression is then calculated 
as percent of CON, i.e., 100 x (lowest number of cycles required to visualize an amplicon for 
CON samples/lowest number of cycles required to visualize and amplicon for XPC samples).  
Invasion gene expression assays were performed in triplicate for both groups (XPC and 
CON) in each of the three separate experiments, with rpoS used as the housekeeping gene 
control whose expression does not change significantly.  That is, rpoS amplicons are 
typically observed at 25-30 cycles whereas hilA amplicons were typically observed at a wider 
range (10-35) of cycles.  Data were pooled in order to calculate the Mean ± SEM for three 
experiments performed separately.    
5.3.8 Assessment of the Antibiotic Resistance of Salmonella Recovered from 
Broiler Chickens 
On D21, 28, 35, 42, and 49, approximately 20% of Salmonella recovered from broiler 
chickens were assessed for resistance to chloramphenicol at the breakpoint concentration (32 
g/mL; (Institute, 2015).  Chloramphenicol was chosen since resistance to this antibiotic is 
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encoded by the SGI1 integron present in the input Salmonella isolate (Wu et al., 2002).  
Individual black-centered colonies from XLD plates (n=96/treatment group) were inoculated 
into an individual well of a 96-well dish containing 200 L of LB broth.  Bacteria were 
grown statically overnight at 37oC to an OD600 equal to approximately 0.3, which 
corresponds to a concentration of 3 x 108 CFU/mL.  Approximately 3 L of the growth was 
pin-replicated into a fresh 96-well dish in which each well contained 32 g/mL of 
chloramphenicol in 200 L of LB broth.  Percent chloramphenicol resistance was calculated 
as 100 x (number of wells in which Salmonella grew in the presence of chloramphenicol/96).  
Chloramphenicol susceptibility assays were performed for both groups (XPC and CON) in 
each of the three separate experiments. 
5.3.9 Assessment of the Presence of the Antibiotic Resistance-Encoding Integron 
in Salmonella Recovered from Broiler Chickens 
To determine if the changes in chloramphenicol resistance were due to loss of the 
SGI1 (Salmonella genomic island 1) integron from the input strain, a PCR assay was 
performed to determine the qualitative presence of the SGI1 integron.  Recovered Salmonella 
colonies were individually inoculated into LB broth in 96-well dishes in the absence of 
chloramphenicol.  Bacterial growth was then subjected to a qualitative PCR assay developed 
and previously described by Carlson et al. (Carlson, 1999).  Percent SGI1(+) was calculated 
as 100 x (number of wells in which Salmonella yielded an SGI1-specific amplicon visualized 
using agarose gel electrophoresis/96).  SGI1 prevalences were determined for both groups 
(XPC and CON) in each of the three separate experiments, with the input strain used as a 
positive control. 
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5.3.10 Statistical Analysis 
For data in which assessments were performed on multiple days (antibiotic resistance, 
invasion, and fecal shedding), statistical comparisons were made using a repeated measures 
analysis of variance with Tukey’s ad hoc test for multiple comparisons (GraphPad Prism, 
Version 6, La Jolla, CA).  For data involving single measurements from each group (large 
intestinal carriage), statistical comparisons were performed using a student’s t-test 
(GraphPad).  Body weight data were analyzed by the general linear model procedure of SAS 
software (Version 8.02, SAS Institute, Cary, NC) with Treatment (CON or XPC), Trial, and 
the interaction Treatment x Trial considered as the main effects.  Absolute weight data were 
transformed to common logarithms prior to analysis.  Mean separations were accomplished 
using LSMEANS with Tukey’s correction.  For all variables under analysis, significant 
differences were defined at P ≤ 0.05.  Statistical trends were consistent when the three sets of 
experiments were examined independently (data not shown). 
 
5.4 Results 
Three individual and independent replications of this experiment were conducted and 
no significant Trial*Treatment or Trial effects were observed, so data were combined for 
analysis.  Data presented in Table 5.1 and Figures 5.1A, 5.1B, 5.2A, 5.2B, 5.3, 5.4, 5.5, and 
5.6 represent the Mean ± SEM for three experiments performed separately.  
Fecal shedding of Salmonella is a potential source of this pathogen for humans who 
consume poultry products.  On D2, 9, and 16, birds were orally inoculated with Salmonella 
Typhimurium and on D21 they were assigned to either the CON or XPC dietary treatment.  
As expected, no significant differences were observed for fecal shedding of Salmonella 
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between chicks assigned to CON and XPC on D21 (6.5x105 versus 6.9x105 CFU/g, 
respectively), as dietary treatments did not start until D21 (Figure 5.1A).  Significant 
differences (P <0.05) in fecal shedding were observed between CON and XPC on D28, 35, 
and 42 with lower fecal shedding of Salmonella in birds fed XPC when compared to the 
CON-fed birds (Figure 5.1A).  On D28, the XPC-fed group had a 2.4-fold decrease (0.38 on 
a log10 scale) in shedding compared to CON-fed birds (2.7x105 versus 6.9x105 CFU/g, 
respectively).  The greatest difference was observed on D42, with an approximately 7.5-fold 
decrease (0.88 on a log10 scale) in shedding for chicks fed XPC (7.7x105 versus 1.2x105 
CFU/g, respectively).  The relative prevalence of fecal shedding D49 (as indirectly measured 
by large intestinal carriage) was significantly less (P < 0.05) in birds fed XPC than CON 
(76% vs. 100%, respectively) (Figure 5.1B). 
Since Salmonella carriage in the large intestine can be a source of contamination for 
poultry meat, the Salmonella load in each bird was determined at the end of the study.  On 
D49, large intestinal sections were excised and subjected to Salmonella culture and 
enumeration that quantifies the intestinal load of Salmonella.  As shown in Figure 5.2A, large 
intestinal carriage was significantly less (P < 0.05) in birds fed XPC compared to CON 
(3,875 vs. 29,023 CFU/g of intestine, respectively; 0.88 log10 reduction).  The relative 
prevalence of large intestinal carriage was significantly less (P < 0.05) in birds fed XPC 
versus CON (71% vs. 100%, respectively) (Figure 2B). 
To determine if the treatment had an effect on broiler performance as previously 
reported after challenge with a different Salmonella serovar (McIntyre, 2013), broilers in 
each group were individually weighed on D21 and 49 and these data are presented in Table 
5.1.  No significant two-way interaction between Treatment and Trial were observed for any 
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of the measurements, therefore only Treatment effects are presented in Table 5.1.  Because of 
the serpentine assignment format, no significant differences in BW (body weight) were 
observed between birds assigned to XPC and CON groups on D21.  By D49, XPC-fed birds 
were significantly heavier than CON-fed birds (3.504 vs. 3.243 kg, respectively).  Birds fed 
XPC from D21 to 49 exhibited significantly heavier weight gain than CON-fed birds (2.613 
vs. 2.343 kg, respectively).  
At all five time points in which Salmonella were recovered and quantitated from the 
birds (D21, 28, 35, 42 and 49), presumptive colonies were collected by group and then 
subjected to a tissue culture invasion assay.  This approach was taken since a similar 
technology (EpiCor®, Embria Health Sciences) has been reported to increase butyrate levels 
in the intestine (Possemiers et al., 2013) and butyrate can decrease Salmonella invasion gene 
expression in vitro (Gantois et al., 2006).  No significant differences were observed for 
invasiveness of Salmonella on D21 (1.06 vs. 1.03%), as dietary treatments did not start until 
D21.  Significant differences (P < 0.05) in invasiveness were observed between CON and 
XPC (1.08% vs. 0.18%, respectively; i.e., a 0.78 reduction on a log10 scale) on D49 with 
Salmonella exhibiting decreased invasiveness following isolation from birds fed XPC when 
compared to the CON-fed birds (Figure 5.3).  This decrease in invasiveness of Salmonella 
coincided with a decrease in the expression of hilA (Figure 5.4), a major regulator of 
Salmonella virulence for mammalian hosts (Bajaj et al., 1995). 
Salmonella recovered from birds were subjected to a chloramphenicol susceptibility 
assay.  This line of study was pursued since the input strain bears a chloramphenicol 
resistance-encoding genetic structure (SGI1) that can be dislodged from Salmonella based on 
previous studies (Brewer et al., 2013).  Figure 5.5 reveals a similar prevalence of resistant 
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Salmonella on D21 in both groups (96 vs. 94%) followed by a decrease in the prevalence of 
chloramphenicol resistance (P < 0.05) in Salmonella recovered from broilers fed XPC on 
D28, 35, 42 and 49, as compared to Salmonella recovered from CON fed birds (57 vs. 88%, 
33 vs. 81%, 15 vs. 78%, and 15 vs. 75%, respectively).  This reduction in chloramphenicol 
resistance was likely due to egress of the SGI1 integron, as presented in Figure 5.6, where 
about 80% of the isolates from the CON-fed birds retained SGI1 yet only 10-20% of isolates 
retained SGI1 in birds fed XPC. 
 
5.5 Discussion 
Salmonella is an insidious problem for the poultry industry, and this problem 
represents a critical food safety hazard.  In addition, there are reports of non-typhoidal 
serovars causing salmonellosis in chickens (Ogunleye et al., 2012; Gong et al., 2016).  
Therefore, identifying mitigation strategies is of paramount importance to the poultry 
industry. 
In this study, the anti-Salmonella effects of XPC were examined and two critical 
indicators of Salmonella contamination (shedding and large intestinal carriage) were 
significantly reduced by XPC.  Both shedding and large intestinal carriage are dependent 
upon pathogen burden and it appears that Salmonella may be less efficient at maintaining an 
attachment to the intestinal tract in the presence of XPC.  The diminished shedding was 
observed at all three time points including just seven days following the initiation of feeding 
XPC.  In the CON-fed broilers, a higher number of Salmonella were present in the large 
intestinal tract, which ultimately increases the risk of pathogen transmission to humans that 
ingest the poultry meat.  These results are consistent with a previous study in which XPC 
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reduced intestinal colonization (Ibukic et al., 2012).  Additionally, the current studies 
revealed a performance benefit for feeding XPC, which is consistent with previous reports 
(Nsereko, 2013) 
McIntyre (2013) reported that broilers, which were orally gavaged on Day 0 with a 
nalidixic acid resistant strain of Salmonella Heidelberg, and fed a diet with and without XPC, 
at an inclusion rate of 1.25 kg/MT, did not differ in BW Gain from D0 to 35 or D0 to 42.  
However, birds fed XPC did exhibit statistically lower cumulative feed conversions to D35 
and 42 and better livability as compared to CON-fed birds (McIntyre, 2013).  In the present 
study, birds were fed the CON diet until they were sorted into dietary treatment groups on 
D21, which was based on BW and Salmonella shedding using a serpentine assignment 
format.  Therefore, it was not unexpected to find no significant differences for BW on D21 
between the XPC- and CON-fed birds.  However, the addition of XPC in the diet, starting on 
D21, resulted in improved BW on D49 and for BW gain from D21 to 49, suggesting that the 
addition of XPC can result in an improvement in a commercially important trait such as BW.   
Other significant and unique findings in this study are the reduction of tissue culture 
invasiveness and SGI1-based antibiotic resistance in the Salmonella recovered from broilers 
fed XPC.  The reduced virulence was manifested by diminished tissue culture invasion 
concordant with a reduction in the expression of hilA, the master regulator of Salmonella 
invasion (Bajaj et al., 1995).  It is unclear how these virulence parameters were improved by 
feeding XPC, but previous studies revealed that XPC increases the gastrointestinal 
production of butyrate (Broomhead, 2012), which is an established repressor of hilA 
expression (Durant et al., 2000).  Nonetheless, the observed magnitude of decreased 
invasiveness is likely to increase the infectious dose for a human as evidenced by a prior 
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study in which this level of diminished invasiveness altered the murine LD50 by 10-fold 
(Carlson et al., 2000).   
For the reduction in antibiotic resistance, this effect was correlated with a loss of the 
SGI1 integron from the input Salmonella strain.  While we have no hypothesis for the 
mechanism by which XPC mediates this expulsion event, previous work revealed that SGI1 
can be lost from Salmonella while in the intestinal tract (Brewer et al., 2013).  
In summary, broilers were significantly less likely to harbor large intestinal 
Salmonella and subsequently shed the pathogen in birds that were fed XPC.  It is unclear if 
this effect is due to decreased attachment or increased clearance of the microbe.   
Additionally, feeding XPC reduced the virulence and antibiotic resistance of the input 
Salmonella strain.  Ultimately, these varying yet beneficial effects will have a marked 
positive effect on food safety in the poultry industry and future mechanistic studies will 
uncover the molecular bases for these effects. 
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5.6 Tables and Figures 
Table 5.1 Feed Efficiency 
 Treatment 
Variable1,2 CON3  XPC3,4,5  P-value 
BW 21d 
0.896 ± 
0.018 
0.881 ± 
0.017 
0.5077 
BW 49d 
3.243 ± 
0.045b 
3.504 ± 
0.044a 
<0.0001 
BW Gain (21-
49d) 
2.343 ± 
0.045b 
2.613 ± 
0.043a 
0.0122 
1. Means ± SEM. 
2. Means across rows within the same variable column with no common superscript 
differ significantly (P < 0.05). 
3. Sample size: CON (n=57) and XPC (n=57) 
4. Diamond V Original XPCTM inclusion rate was 1.25 kg/MT for all diets in the XPC 
treatment group. 
5. Dietary treatment was applied on Day 21. 
Body weights (kg), body weight gains (kg), and statistical probabilities for broilers fed with 
and without Diamond V Original XPCTM and challenged with Salmonella Typhimurium. 
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Figure 5.1 Salmonella fecal shedding (CFU/g) in broilers. Birds were orally inoculated 
with multiple antibiotic-resistant Salmonella Typhimurium on D2, 9, and 16.  Dietary 
treatments, CON (n=57) or XPC (n=57), were applied on Day 21 and Salmonella were 
isolated from feces (using XLD agar) on D21, 28, 35, and 42.  Data represent the Mean ± 
SEM for three experiments performed separately. a,bP < 0.01. 
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Figure 5.2 Prevalence of Salmonella fecal shedding in broilers. Birds were orally 
inoculated with multiple antibiotic-resistant Salmonella Typhimurium on D2, 9, and 16.  
Dietary treatments, CON (n=57) or XPC (n=57), were applied on D21 and Salmonella were 
isolated from feces (using XLD agar) on D21, 28, 35, and 42.       Data represent the Mean ± 
SEM for three experiments performed separately. a,bP < 0.01, a,c0.01 < P < 0.05. 
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Figure 5.3 Large intestinal colonization by Salmonella on Day 49 in broilers. Dietary 
treatments, CON (n=57) or XPC (n=57), were applied on D21.  On D49, all birds were 
euthanized and a section of the large intestine was removed and selectively and quantitatively 
cultured for Salmonella using XLD agar.  Data represent the Mean ± SEM for three 
experiments performed separately. a,bP < 0.01. 
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Figure 5.4 Prevalence of large intestinal colonization by Salmonella on Day 49 in 
broilers. Dietary treatments, CON (n=57) or XPC (n=57), were applied on D21.  On D49, all 
birds were euthanized and a section of the large intestine was removed and selectively and 
quantitatively cultured for Salmonella using XLD agar.   Data represent the Mean ± SEM for 
three experiments performed separately.   a,bP < 0.01. 
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Figure 5.5 Tissue culture invasiveness of Salmonella recovered from broilers 
challenged with Salmonella Typhimurium. Dietary treatments, CON (n=57) or XPC 
(n=57), were applied on D21 and continued until D49 when intestinal samples were taken 
and approximately 30% of the Salmonella recovered (approximately 105 CFU) were 
subjected to the invasion assay using mammalian tissue culture cells and a multiplicity of 
infection equal to at least one.  Percent invasion is a calculated as 100 x (number of 
Salmonella recovered from within the tissue culture wells/number of Salmonella added to the 
tissue culture wells).  Data represent the Mean ± SEM for three experiments performed 
separately.  a,bP < 0.01. 
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Figure 5.6 Expression of hilA in Salmonella recovered from feces of broilers 
challenged with Salmonella Typhimurium. Dietary treatments, CON (n=57) or XPC 
(n=57), were applied on D21 and continued until D49 when intestinal samples were taken 
and approximately 20% of the Salmonella recovered were subjected to the RNA isolation 
and semi-quantitative RT-PCR as previously described (Carlson et al., 2007).  Expression 
was then calculated as percent of CON, i.e., 100 x (number of cycles required to visualize an 
amplicon for CON samples/number of cycles required to visualize an amplicon for XPC 
samples).  Data represent the Mean ± SEM for three experiments performed separately.  a,bP 
< 0.01 
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Figure 5.7 Chloramphenicol resistance of Salmonella recovered from the feces (D21, 
28, 35, and 42) or intestines (D49) of broilers. Dietary treatments, CON (n=57) or XPC 
(n=57), were applied on D21.  On D21, 28, 35, 42, and 49, approximately 20% Salmonella 
recovered from broiler chickens were assessed for resistance to chloramphenicol at the 
breakpoint concentration (32 g/mL; CLSI, 2008).  Data represent the Mean ± SEM for three 
experiments performed separately. a,bP < 0.01 
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Figure 5.8 Presence of SGI1 in Salmonella recovered from the feces (D21, 28, 35, and 
42) or intestines (D49) of broilers. Dietary treatments, CON (n=57) or XPC (n=57), were 
applied on D21.  Recovered Salmonella colonies were individually inoculated into LB broth 
in 96-well dishes in the absence of chloramphenicol.  Bacterial growth was then subjected to 
a PCR assay developed and previously described by Carlson et al. (1999).  Percent SGI1(+) 
was calculated as 100 x (number of wells in which Salmonella yielded an SGI1-specific 
amplicon/96).  Data represent the Mean ± SEM for three experiments performed separately. 
a,bP < 0.01, a,c0.01 < P < 0.05 
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CHAPTER 6.   THE C5AR1 ANTAGONIST NDT9513727 BLOCKS THE ANTI-
SALMONELLA EFFECTS OBSERVED IN BROILERS FED XPCTM, A 
SACCHAROMYCES CEREVISIAE FERMENTATION PRODUCT 
K.M. Feye1, K.L. Anderson1, H.O. Pavlidis2, G. R. Schmidt-McCormack3, N. C. 
Eischen1, J. P. Carroll4, S.A. Carlson1 
 
Modified from manuscript to be submitted to: Poultry Science 
 
1. Department of Biomedical Sciences, Iowa State University, Ames, Iowa, USA 
2. Diamond V, Cedar Rapids, Iowa, USA  
3. Interdepartmental Neurobiology, Iowa State University, Ames, Iowa, USA 
4. Interdepartmental Microbiology, Iowa State University, Ames, Iowa, USA 
6.1 Abstract 
The ability of the functional metabolites of Diamond V Original XPCTM (XPC) to 
reduce Salmonella enterica has been established across multiple food animal species.  
Previous gene expression studies suggested that the effects of XPC may be based on an 
upregulation of part of the complement cascade.  The C5a complement protein, and its 
cognate receptor (C5aR1), contributes to the clearance of Salmonella in mammals and it may 
have the same properties in poultry.  In order to evaluate the role that C5aR1 plays in the 
anti-Salmonella effects of XPC, we used a putative C5aR1 antagonist to block the effects of 
XPC.  The drug NDT9513727 is an established bioavailable C5aR1 antagonist that was used 
for this study.  Chicks were infected with Salmonella enterica Typhimurium DT104 on Days 
2, 8, and 15 post-hatch.  Salmonella-negative chicks were removed on Day 21, and the 
remaining chicks were redistributed to equalize body weights and Salmonella shedding 
between groups.  The broilers were then placed on either the control diets (CON or XPC 
only) or experimental diets (NDT9513727 alone or XPC + NDT9513727).  Fecal samples 
were collected on Days 21, 28, 35, and 42 followed by a terminal ceca collection on Day 49.  
Broilers were monitored for differences in Salmonella fecal shedding and colonization, as 
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well as feed efficiency.  Significant differences in feed efficiency as well as Salmonella 
shedding and colonization (p< 0.05) were observed in chicks that were treated with XPC 
versus the three other groups.  That is, NDT9513727 reduced the positive effects of XPC.  
Therefore, it is likely that C5a and C5aR1 are central, yet possibly indirect, to the anti-
Salmonella effects of XPC.  
 
6.2 Introduction 
Salmonella is the leading etiological agent of foodborne illness and death in the 
United States (Besser, 2017; Finstad et al., 2012).  While Salmonella are not overt pathogens 
in poultry in the U.S., mollifying the vertical transmission of Salmonella through the food 
chain is necessary to protect human health (Besser, 2017).  As a result of this threat, 
regulations meant to safeguard consumers are an encumbrance for the poultry industry.  
Many mitigation products are available to poultry producers, including XPCTM (Diamond V, 
Cedar Rapids, IA), which has shown significant potential to abate Salmonella in food animal 
production (Feye et al., 2016; Feye et al., 2016).  The specific chemical composition of XPC 
is not available but it is known is that XPC is comprised of dried Saccharomyces cerevisiae 
fermentates containing over 300 distinct compounds (Jensen et al., 2008; Jensen et al., 2007; 
Jensen et al., 2011; Possemiers et al., 2013).  When XPC is used as feed additive, it 
apparently generates changes in the microbiome that impact Salmonella biology and the host 
immune system (Park et al., 2017; Roto et al., 2015; Rubinelli et al., 2016).  
The anti-Salmonella effects of XPC in poultry have been well-documented in field 
and laboratory experiments.  XPC has three major anti-Salmonella effects: the reduction of 
antibiotic resistance, the attenuation of virulence mechanisms, and the reduction of 
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Salmonella shedding and colonization (Feye et al., 2016).  That is, XPC-fed animals harbor 
Salmonella that are less likely to cause human illness and isolates are more likely to be 
susceptible to antibiotics.  Moreover, the dampened virulence is sustained in the pathogen 
and does not return to baseline until it apparently passes through at least two additional hosts 
(Chapter 3).  
A growing body of evidence suggests that the anti-Salmonella effects of XPC are a 
result of changes to the microbiome (Park et al., 2017; Roto et al., 2015; Rubinelli et al., 
2016).  This microbiome shift enhances the production of butyrate which is an established 
transcriptional down-regulator of hilA, the master regulator of mammalian cell invasion for 
Salmonella (Bajaj et al., 1995; Durant et al., 2000).  This effect results in a less invasive 
pathogen, but it does not explain the reduction of Salmonella load and in shedding from 
animals fed XPC.  Additional evidence suggests that XPC beneficially modulates the 
immune system resulting in the improved clearance of pathogens, which is likely 
downstream of the microbiome changes initiated by XPC (Blacher et al., 2017; Chou et al., 
2017; Eloe-Fadrosh and Rasko et al., 2013; Jensen et al., 2007a; Pan and Yu, 2014; Park et 
al., 2017).  This theory is termed the Salmonella clearance hypothesis, whereby XPC 
beneficially stimulates the immune system and improves innate effector function resulting.  
As a result, there is an improved clearance of Salmonella exhibited by broilers fed an XPC-
containing diet.  There are three pieces of evidence that lend credence to the enhanced 
Salmonella clearance hypothesis: gene expression studies (Chou et al., 2017), in vivo results 
from cattle on an XPC-containing diet (Feye et al., 2016), and ex vivo experiments evaluating 
the phagocytosis of Salmonella by innate effector cells (Chapter 3).  
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In the gene expression studies, Chou et al. demonstrated that complement protein C3 
gene expression was upregulated 7.36-fold above the background in the spleens of broilers 
fed an XPC-containing diet (Chou et al., 2017).  C5a acts as a chemoattractant for neutrophils 
and interacts with its cognate G-protein coupled receptor, C5aR1, to improve the innate 
effector response and perpetuate an appropriate inflammatory response (Kolev et al., 2014; 
Lee et al., 2008; Li et al., 2012).  Central to the Salmonella clearance hypothesis, the C5aR1 
actions lead to neutrophil infiltration into the lamina propria, the perpetuation of the response 
of adaptive effector cells, and the resolution of the infection (Coburn et al., 2007; Kurtz et al., 
2017).    
The second and third pieces of evidence to support the enhanced Salmonella 
clearance hypothesis arise from two studies that evaluated the ability of XPC to abrogate 
Salmonella in cattle.  Feye et al. (2016) reported a reduction of Salmonella recovered from 
the peripheral lymph nodes of cattle fed an XPC-like product (Feye et al., 2016).  This could 
be due to one of two possibilities: (1) XPC fortifies gut barrier integrity and Salmonella are 
unable to invade the lamina propria; or, (2) the Salmonella cannot shut down host 
surveillance strategies and as a result are successfully cleared.  The third piece of evidence 
was provided by an ex vivo experiment that evaluated the difference in the clearance of 
Salmonella from the whole blood of cattle either fed XPC or a Control diet lacking XPC 
(Chapter 3).  These data revealed that enhanced Salmonella killing in whole blood cells 
recovered from animals fed XPC.  Taken together, these data support the enhanced 
Salmonella clearance hypothesis, which we further theorize to include C5aR1.  
As a result of preliminary evidence and the established role of C5aR1 for clearing 
Salmonella, it became prudent to determine if C5aR1 activity underlies the anti-Salmonella 
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effects of XPC.  The working hypothesis of this study is that blocking the C5aR1 receptor 
will reduce the XPC-mediated effects on Salmonella.  To inhibit C5aR1, we used the well-
established and bioavailable antagonist designated as NDT9513727 (Brodbeck et al., 2008; 
Klos et al., 2009; Klos et al., 2013).  
 
6.3 Materials and Methods 
6.3.1 Experimental Design and Husbandry 
Three independent cohorts were conducted at Iowa State University in a Biosafety 
Level-2 facility.  Each study started with one-day old standard industry Cobb 100 chicks that 
were purchased from Welp Hatchery (Bancroft, Iowa).  The protocol for these experiments 
was approved by the Institutional Animal Care and Use Committee (IACUC) at Iowa State 
University.  The animal protocol is very similar to those executed by Anderson, et al. and 
Feye, et al. (Anderson et al., 2015; Feye et al., 2016) 
Each of three experiments started with 25 chicks per treatment group, i.e., 75 chicks 
in total per group.  At 1-day post hatch, broilers were placed in brooder pens (0.09m2 with 10 
broilers per pen) with ad libidum access to chick feed and water.  The conditions of the 
brooder pens were established and maintained by the protocol delineated in Feye et al., 2016 
(Feye et al., 2016).  Starting at two weeks post-hatch and throughout the remainder of the 
study, the broilers were moved to elevated Tenderfoot Decks (13.4 m2 per treatment group) 
with consistent and easy access to feed and fresh water.  The rooms were cleaned and 
monitored daily as to ensure a consistent environment and access to fresh water and food. 
All of the broilers were fed a standard starter diet consisting of 24% crude protein 
(Tractor Supply Company, Brentwood, TN) from arrival to D21.  At D21, Salmonella 
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shedding from the broilers was quantitatively assessed on a CFU/gram of feces basis.  The 
broilers were then segregated into one of four treatment groups as per Feye et al., (2016) and 
fed a grower/finisher diet (Feye et al., 2016).  The XPC group received 1.25kg/MT of XPC 
(Diamond V, Cedar Rapids, IA).  The NDT9513727 group received the C5aR1 antagonist 
NDT9513727 (Tocris Bioscience, Pittsburg, PA) at 33 ng/kg of grower/finisher feed.  This 
dose was chosen based on allometric scaling and the established IC50 of the antagonist 
(Brodbeck et al., 2008).  The NDT9513727+XPC group contained NDT9513727 and XPC at 
the aforementioned respective concentrations.  The CON diet contained neither XPC nor 
NDT9513727.  
The investigators were blinded as to the identity of groups throughout the course of 
study, and the designation of each group changed with each cohort.  Each group was simply 
known as A, B, C, or D to the researchers.  The identities of each treatment group were 
matched to a different alphabetic designation for each study.  After the data was collected 
and at the end of each study, a third party revealed the identity of the groups to the 
researchers.   
6.3.2 Salmonella Challenge 
Upon arrival to Iowa State University, broilers were qualitatively evaluated for the 
presence of Salmonella.  In order to evaluate the broilers for Salmonella, approximately 0.1-
0.3 grams of freshly voided feces were collected into sterile conical tubes containing 10 mL 
of Luria Broth (LB) (Invitrogen, Carlsbad, CA).  The samples were vortexed and 100 L 
aliquots were distributed onto Xylose Lysine Deoxycholate (XLD) agar (Fischer Scientific, 
Lenexa, KS).  The XLD agar was chosen because it is selective for Enterobacteriaceae and 
differential for Salmonella (Feye et al., 2016).  The individual aliquots were spread evenly 
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onto individual XLD plates using sterile plastic spreaders and allowed to absorb into the 
media.  The plates were then inverted and incubated overnight at 37C.  The XLD agar was 
evaluated for Salmonella 24 hours post-inoculation.  Colonies were considered to be 
Salmonella if they were round with even white or yellow margins and black centers.   
On D2, 8, and 15, broilers were orally inoculated with of Salmonella enterica 
Typhimurium phagetype DT104 as per Feye et al., 2016 (Feye et al., 2016).  Starting on D20, 
the broilers were banded with identification numbers and individually analyzed for 
quantitative shedding on a gram of feces/CFU basis as per Feye et al., 2016 (Feye et al., 
2016).  The Salmonella was quantified on a CFU/gm of feces and was calculated for each 
broiler.   
Any broilers that were not shedding Salmonella were removed from the study on 
D21.  In order to distribute the bird weights and Salmonella shedding evenly across treatment 
groups, a serpentine block method was utilized to ensure an equal distribution of both factors 
as described in Feye et al., 2016 (Feye et al., 2016).  The means of each factor within each 
group were taken to ensure that each treatment group had on average the same distribution of 
weights and shedding prior to the start of the feed trial phase (D21 to D49).  
6.3.3 Assessment of Salmonella shedding and Cecal Colonization During 
Treatment 
Quantitative analysis of the shedding of each bird was performed throughout the 
remainder of the study as previously described in Feye et al., 2016 (Feye et al., 2016).  
Quantitative analysis of the cecal colonization of each bird was performed on Day 49 as 
previously described in Feye et al., 2016 (Feye et al., 2016).   
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6.3.4 Assessment of Feed Efficiency  
Feed efficiency was determined based on the protocol from Feye et al., 2016 (Feye et 
al., 2016d).  The broilers were weighed on D21 on D49.  The amount of feed consumed was 
also monitored. The feed:gain ratio was calculated using the following formula: (total feed 
consumed)/(start weight in kg – end weight in kg).  Any bird that died between D21 and D49 
was weighed and included in the calculations.  
6.3.5 Statistical Analyses 
For data with multiple sampling time points (prevalence, shedding), a repeated 
measures analysis was used with the Bonferroni ad hoc test for multiple comparisons (Prism 
Graph Pad 7.0).  Since the level of shedding at D21 was different between experiments, all 
shedding was normalized to that observed on D21 for a given experiment.  For feed 
efficiency and cecal colonization, an analysis of variance (ANOVA) was conducted with the 
Tukey’s ad hoc correction for multiple comparisons.  
6.4 Results 
Figures 1 through 5 are representative of the combination of three independent 
experiments.  There was an inter-experiment difference regarding Salmonella shedding on 
D21.  In an effort to address this issue, D21 served as the normalization point for each 
individual experiment.   That is, shedding is reported as % of Day21 where Day 21 equals 
100%. 
6.4.1 Assessment of Feed Efficiency 
Previous studies indicated that XPC boosts the feed efficiency of poultry (Feye et al., 
2016) and thus C5aR1 antagonism should abrogate this production benefit if C5 is involved 
in the mechanism of XPC.  To address this hypothesis, we utilized the feed:gain (F:G) ratio 
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as it is a global and non-specific indicator of feed conversion.  As seen in Figure 6.1, the 
inclusion of NDT9513727 negated the XPC-mediated enhancement of feed conversion.  That 
is, the NDT9513727 + XPC results were similar to that observed with the Control or 
NDT9513727 diets.  
6.4.2 Assessment of Salmonella Shedding from D21 to D42 
As shown in previous experiments, XPC reduces Salmonella shedding in broilers 
(Feye et al., 2016).  As shown in Figure 6.2, which represents the amount of Salmonella shed 
relative to that observed on D21, NDT9513727 dissipated the XPC-mediated reduction of 
Salmonella shedding.  Differences began to emerge on D28 and were fully evident on D35 
and D42.  
6.4.3 Assessment of Prevalence of Salmonella Shedding from D21 to D42 
 Previous studies revealed that XPC will reduce the prevalence of Salmonella 
shedding in broilers (Feye et al., 2016).  That is, XPC increases the number of birds that shed 
no Salmonella.  As shown in Figure 6.3, NDT9513727 eliminated the XPC-mediated effect 
on the prevalence of Salmonella shedding.  This effect was observed at all three time points.  
6.4.4 Salmonella Cecal Colonization on D49 
Evisceration and de-feathering are important steps in the vertical transmission of 
Salmonella from poultry to the food supply.  The ability of XPC to reduce colonization and 
prevalence is essential in mitigating that threat.  In order to determine if NDT951372795 
negates the effects of XPC, we quantitatively assessed the broilers for Salmonella 
colonization of the ceca.  As shown in Figure 6.4, NDT9513727 inhibited the ability of XPC 
to prevent Salmonella colonization of the ceca.  This trend was also noted for the prevalence 
of cecal colonization, as shown in Figure 6.5. 
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6.5 Discussion 
The studies presented herein were designed to address the hypothesis that the C5aR1 
is involved in the beneficial effects of XPC on Salmonella in broilers.  This hypothesis was 
formulated based on gene expression studies revealing an upregulation of the expression of 
C3, a complement protein that is closely upstream of C5aR1.  Based on data presented 
herein, the C5aR1 receptor is a likely component of the effects of XPC on chicken 
immunobiology as some of the activities of XPC are blocked by the putative C5aR1 
antagonist designated as NDT9513727.  Not all of the benefits of XPC were negated by 
NDT9513727.  XPC can reduce Salmonella virulence and antibiotic resistance (Feye et al., 
2016), but NDT9513727 had no effect on these parameters (data not shown). 
While we have not directly shown that NDT9513727 inhibits C5aR1 in broilers, we 
have demonstrated that NDT9513727 is bioavailable and exhibits biological activity in the 
chicken by increasing Salmonella shedding, colonization, prevalence, and reducing feed 
efficiency in the presence of XPC.  Future studies will ascertain the ability of NDT9513727 
to perturb C5a binding to the C5aR1.  Nonetheless, our results are consistent with the 
established ability of C5a to act as a chemoattractant for neutrophils.  This complement 
protein interacts with C5aR1 to improve the innate effector response and perpetuate an 
appropriate inflammatory response (Klos et al., 2009).  Moreover, our studies bolster the 
Salmonella clearance hypothesis whereby the actions of C5aR1 lead to neutrophil infiltration 
into the lamina propria, the perpetuation of the response of adaptive effector cells, and the 
resolution of the infection (Boothby et al., 2015; Klos et al., 2009; Kolev et al., 2014; Lee et 
al., 2008; Li et al., 2012; Ricklin et al., 2010; Schraufstatter et al., 2002). 
The use of XPC as a production strategy in food animals to improve feed efficiency is 
evolving to be an important tool in improving food safety.  The mechanisms behind the 
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efficacy of XPC are rapidly being uncovered.  By understanding these pathways further, 
potentially new mitigation tools can be created and will expand upon the beneficial utility of 
products like XPC. 
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6.6 Figures 
 
Figure 6.1 Effects of NDT9513727 on XPC-mediated enhancement of feed efficiency. 
Broilers were fed the Control diet, XPC, NDT9513727, or NDT9513727 + XPC.  Feed 
efficiency was monitored from D21 through the terminal endpoint on D49.  The data 
represents the mean + SEM of the three independent experiments.  For the XPC group, all 
pairwise comparisons were statistically significant at p<0.05 (i.e., * p<0.05 versus XPC). 
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Figure 6.2 Effects of NDT9513727 on XPC-mediated reduction in Salmonella 
shedding. The broilers were fed the four diets starting on D21 and were monitored for 
Salmonella shedding from D21 through D42.  Shedding was normalized to D21 as the initial 
level of Salmonella shedding varied per experiment, though the pattern maintained itself.  
The data represents the mean + SEM of the three independent experiments.  * p<0.05, ** 
p<0.005, and *** p<0.0001 versus XPC. 
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Figure 6.3 Effects of NDT9513727 on XPC-mediated reduction in the prevalence of 
Salmonella shedding. The broilers were fed the four diets starting on D21 and were 
monitored for Salmonella shedding from D21 through D42.  The data represents the mean + 
SEM of the three independent experiments.  * p<0.05 versus XPC. 
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Figure 6.4 Effects of NDT9513727 on XPC-mediated reduction in the colonization of 
Salmonella in the ceca. The broilers were fed the four diets starting on D21 and were 
monitored for Salmonella cecal colonization on D49.  The data represents the mean + SEM 
of the three independent experiments.  For the XPC group, all pairwise comparisons were 
statistically significant at p<0.05 (i.e., * p<0.05 versus XPC). 
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Figure 6.5 Effects of NDT9513727 on XPC-mediated reduction in the prevalence of 
Salmonella in the ceca. The broilers were fed the four diets starting on D21 and were 
monitored for Salmonella cecal colonization on D49.  The data represents the mean + SEM 
of the three independent experiments.  For the XPC group, all pairwise comparisons were 
statistically significant at p<0.05 (i.e., * p<0.05 versus XPC). 
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CHAPTER 7.   DISCUSSION 
The evidence presented herein supports the central hypothesis of this dissertation.  
That is, XPC exhibits anti-Salmonella properties resulting in the reduction of Salmonella 
prevalence, shedding, colonization, virulence, and antibiotic resistance in poultry and cattle.  
Further, XPC stimulates the immune system to efficiently phagocytize Salmonella, likely 
through the actions of C5aR1.  As a result of our data, XPC becomes valuable tool to abate 
Salmonella and improve food safety. 
 
7.1  XPC Reduces Salmonella Shedding and Colonization and Future Directions 
In every study conducted by our group, there was a reduction in Salmonella 
prevalence, shedding, and colonization.  Therefore, XPC is successful in mitigating the threat 
of Salmonella in poultry and cattle production.  As a result of the data, Diamond V 
successfully validated the anecdotal reports that spurred on these investigations.  
An unexpected result of XPC in cattle was the disproportionate reduction in the 
prevalence of naturally acquired Dublin, Typhimurium, and Newport.  Interestingly, there 
may be serovar-specific metabolite preferences that dictate the emergence or disappearance 
of a particular serovar (Hayward et al., 2015; Rubinelli et al., 2016; Stecher et al., 2012; 
Steeb et al., 2013).  XPC affects changes to the microbiome and alter the metabolites 
available to Salmonella (Park et al., 2017; Roto et al., 2015; Rubinelli et al., 2016).  
Therefore, in order to explore this phenomenon further, metabolomics studies targeting the 
interaction between the microbiome and various Salmonella serovars (e.g. Dublin, 
Typhimurium and Newport) need to be conducted in cattle fed XPC. 
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7.2 XPC Attenuates Salmonella and Future Directions 
Despite what would appear to be an optimal paradigm, the abrogation of Salmonella 
to improve food safety does not necessarily require the complete removal of the pathogen 
from food animals.  XPC attenuates the virulence of Salmonella while minimizing its burden 
in cattle and poultry (Feye et al., 2016; Feye et al., 2016).  In doing so, XPC showed the 
capacity to succeed where antibiotics have failed, producing a weaker pathogen without 
spurring a resistance response.  Part of this attenuation may come from the butyrate-driven 
reduction of the expression of the T3SS master regulator, hilA (Bajaj et al., 1995; Golubeva 
et al., 2016; Golubeva et al., 2012).  
It is currently unknown as to how the changes in the microbiome alter Salmonella 
biology.  In order to fully investigate the scope of how XPC affects Salmonella, Salmonella 
regulatory networks and transcriptional responses must be queried through next-generation 
sequencing.  Whole Genome Correlation Network Analysis can then be employed to 
mathematically correlate the transcriptional response of Salmonella with any known 
quantifiable phenotype, such as virulence factors or antibiotic susceptibility (Langfelder and 
Horvath et al., 2008).  These clusters of phenotypically correlated genes, termed eigengene 
groups, can then be exported into a network analysis software program and evaluated for 
novel transcriptional regulatory relationships (Langfelder and Horvath et al., 2008).  By 
utilizing this approach, we can identify currently unknown pathways or gene relationships 
whose XPC-mediated vulnerabilities may be exploited for the development of novel 
mitigation tools.  
Altogether, investigations into the XPC-mediated reduction in virulence were 
productive and important for food safety.  A diminution of Salmonella transmitted through 
the food chain may profoundly reduce the overall threat of Salmonella, resulting in less 
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morbidity and mortality worldwide.  Thus, XPC has succeeded where antibiotics have failed 
by mitigating Salmonella without collateral effects.  
7.3 XPC Reduces Antibiotic Resistant Genotypes and Phenotypes of Salmonella and 
Future Directions 
In an era where antibiotic resistance renders modern therapeutics ineffective, a re-
establishment of antibiotic susceptibility in foodborne pathogens like Salmonella is powerful.  
When evaluating potential tools to replace antibiotics, the topic of antibiotic resistance 
should be considered paramount as new tools should not worsen an already pervasive 
problem.  Crucially, XPC directly combats antibiotic resistance in Salmonella.  It can even be 
argued that, while anti-shedding and anti-colonization effects are important, the successful 
reduction in multi-modal mechanisms of antibiotic resistance are pivotal to the future of XPC 
and its derivatives. 
The discovery of a total reduction in antibiotic resistance, including human clinical 
antibiotics (Feye et al., 2016; Feye et al., 2016), is provocative by itself.  However, from a 
basic science perspective, additional questions arise as to whether or not there is a broader 
scope that may be explored by expanding upon the data presented.  The maintenance of 
antibiotic resistance-conferring plasmids and transposable elements are energetically 
expensive for bacteria.  In the controlled experiment in poultry (Chapter 4), the SGI-1 
integron was undetectable in the majority of animals fed XPC.  The probable loss of the 
integron is interesting when compared to other groups studying SGI-1 stability in 
Salmonella.  These groups support the argument that the loss of the penta-resistant phenotype 
does not necessarily correlate with a loss of the integron after multiple passages (Huguet et 
al., 2016).  In fact, experiments produced by these groups go even further and demonstrate 
that the loss of the integron is rare as it is nearly impossible to remove from the genome once 
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it is inserted (Kiss, 2012).  The use of XPC data not only demonstrates a reduction in 
antibiotic resistance phenotypes, but a complete and uncharacteristic loss of a selfish and 
stable integron due to the use of XPC. 
For this reason, our data evaluating the genotypic and phenotypic changes in 
antibiotic resistance of Salmonella are particularly powerful because XPC is able to 
destabilize an extraordinarily stable integron.  Therefore, it will be necessary to further 
understand the DT104 integron and the changes that result to the biology of Salmonella that 
governs its loss.  It is theorized that in order to destabilize the DT104 integron, one of two 
events need to occur: (1) the bacteria harboring this integron die; or, (2) a stable mutation or 
methylation of the genomic sequence for the toxin occurs, which uncouples the system and 
the bacteria evade suicide.   
We can directly address this question in future work using both bioengineered tracer 
strains of Salmonella DT104 to examine integron mediated changes within the Salmonella 
population as well as COLD-PCR to evaluate the methylation of the integron.  Scientists 
have started to bioengineer tracer strains with sequence tags inserted into inert regions of the 
genome with hopes of evaluating the spread of Salmonella between poultry flocks (Yang et 
al., 2017).  Herein it is proposed that a second, highly specific tag could easily be inserted 
into an inert region of the Salmonella SGI-1 that is protected by the toxin-anti-toxin system, 
sgiTA (Huguet et al., 2016).  We could then directly determine if the Salmonella population 
that persists within a flock has the integron but loses the phenotype, dies, or if the Salmonella 
completely loses the integron all together and persists.  If this data are coupled with COLD-
PCR, which exploits the Tm differences between methylated and un-methylated regions of 
DNA, we could then address whether or not the loss of antibiotic resistance was due to 
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methylation (Kurdyukov and Bullock, 2016).  It is important to understand this mechanism to 
try to predict if evasion by the selfish elements are possible as a result of uncoupling the 
toxin-anti-toxin system.  It is also crucial to grasp whether or not the population of 
Salmonella that reside within a poultry flock still have, but do not express the integron on a 
much larger scale.  
Obviously, antibiotic resistance is impactful worldwide.  XPC is able to produce a 
multi-modal reduction in antibiotic resistance resulting in pan-sensitivity in Salmonella 
recovered from animals fed an XPC-containing diet.  Since Salmonella and other 
Enterobacteriaceae serve as reservoirs for antibiotic resistant genes, the loss of these 
elements from those populations may result in a restoration of antibiotic susceptibility to the 
commensal Enterobacteriaceae over time.  More research is needed to fully support that 
notion, but if proven, would be significant.  
 
7.4 XPC, C5aR1, and Future Directions 
Throughout the execution of this dissertation, we discovered that phagocytes 
recovered from cattle on XPC-containing diets were able to clear Salmonella more efficiently 
when compared to the controls.  This data corresponds with a reduction in Salmonella 
recovered from peripheral lymph nodes, which are an emerging source for beef 
contamination.  The mechanism behind this superior clearance of Salmonella by phagocytes 
likely lies within the complement system, specifically the C5aR1 pathway.  Evidence 
supports this theory as the immunostimulatory effects of XPC were reversed by treating 
animals with NDT9513727, which is a putative antagonist for C5aR1.  Furthermore, 
unpublished evidence also suggests that there is no difference in hilA expression and 
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antibiotic resistance between NDT9513727, NDT9613727+XPC, and XPC treatment groups 
when compared to the Control.  Thus, the direct anti-virulence and anti-antibiotic resistance 
effects mediated by XPC are independent of the activation of the C5aR1 pathway. 
The ability of XPC to modulate the immune system is likely global and is even 
demonstrated in the establishment of the immune system of poultry (Chou et al., 2017), the 
host-microbiome axis, and the ability to combat pathogenic assaults.  As a result, XPC 
exhibits a multi-modal approach that is anti-Salmonella, through directly weakening 
Salmonella and indirectly improving the clearance of the pathogen.   
 
7.5 Conclusions 
Likely, the anti-Salmonella effects demonstrated by this dissertation are multi-modal 
and interconnected.  These interrelated relationships are governed by the modulation of the 
microenvironment of the gut.  The tuned immune system stabilizes the gut microenvironment 
and barrier functions, and results in improving animal health and feed efficiency (Blacher et 
al., 2017; Cho and Blaser, 2012; Eloe-Fadrosh and Rasko, 2013; Pan and Yu, 2014; Yan et 
al., 2017).  
Importantly, XPC serves as an invaluable tool to improve feed efficiency in food 
animal production.  As antibiotics are slowly phased out world-wide, the niche will need to 
be filled by a product like XPC that has demonstrated efficacy across species.  Because XPC 
is immunostimulatory and is anti-Salmonella, it directly satisfies the void left by antibiotics 
in food animal production. 
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